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Nowadays, soy is one of the most used ingredients in the formulation of fish 
feed, due to the ample market supply, lower market price, high protein 
concentration and favorable amino acid composition. Nevertheless, soybean 
meal products are rich and primary diet source of phytoestrogens, as genistein, 
which may have a potential negative impact on growth, hormonal regulation 
and lipid metabolism in fish. The principal aim of this study was to better 
understand in vivo and in vitro genistein’s effects on lipid metabolism of 
rainbow trout. In adipose tissue it was showed an unclear role of genistein on 
lipid metabolism in rainbow trout, and in liver an anti-obesogenic effect, with 
an up-regulation of autophagy-related genes LC3b (in adipose tissue) and 
ATG4b (in liver and adipose tissue), a down-regulation of apoptosis-related 
genes CASP3 (in adipose tissue) and CASP8 (in liver). An increase of VTG 
mRNA levels in liver was also observed. Genistein partially exerted these 
effects via estrogen- receptor dependent mechanism. In white muscle, genistein 
seemed to promote lipid turnover, up-regulating lipogenic (FAS and LXR) and 
lipolytic (HSL, PPARα and PPARβ) genes. It seemed that genistein could exert 
its lipolytic role via autophagic way (up-regulation of ATG4b and ATG12l), not 
through an apoptotic pathway (down-regulation of CASP3). The effects of 
genistein on lipid-metabolism and apoptosis-related genes in trout muscle were 
not dose-dependent, only on autophagy-related genes ATG4b and ATG12l. 
Moreover, a partial estrogenic activity of this phytoestrogen was also seen. 
Through in vitro analysis (MTT and ORO assay), instead, it was observed an 
anti-obesogenic effect of genistein on rainbow trout adipocytes, and this effect 
was not mediated by ERs. Both in vivo and in vitro, genistein exerted its effects 




World aquaculture production has increased significantly in the last 50 years , 
with an average annual growth rate of 6.1% in volume between 2004 and 2006 
(FAO, 2009). Fish meal and fish oil are the main raw materials used in the 
formulation of fish feeds. Due to the expansion of aquaculture, marine fisheries 
will not be able to sustain the needs of aquaculture in the not too distant future. 
The global demand for fishmeal for aquafeeds may exceed total available 
supplies around the year 2020 and for fish oil well before 2010 (New& 
Wijkstroem, 2002). Thus, alternatives to the use of marine materials in fish 
feeds must be found. Several studies have investigated the replacement of fish 
oil by vegetable oils in fish feed. Partial replacement of fish oils by vegetable 
oils such as rapeseed, soybean, linseed or palm oils in fish feeds has no negative 
impacts on growth and survival of Atlantic salmon (Rosenlund et al., 2001), 
brook char (Guillou et al., 1995), gilthead sea bream and European seabass 
(Izquierdo et al., 2003) and rainbow trout (Greene & Selivonchick,1990; 
Caballero et al., 2002). Regarding protein supply, soybean meal (SBM) and soy 
protein concentrate (SPC) are ingredients currently incorporated in aquafeeds to 
partially replace fish meal without negative effects on growth performance 
(Kaushik et al., 1995; Refstie et al., 2010).  
 A class of compounds of high concentration in soy are isoflavones that, for 
their capacity of  binding to and activating estrogen receptors (Latonnelle et al., 
2002), were classified as phytoestrogens. The phytoestrogen of greatest 
abundance in soy products is genistein, which is present in defatted SBM at an 
average of 114,7 mg/100g SBM (Bhagwat et al., 2008), although concentrations 
potentially vary between seasons and soybean varieties (Wang and Murphy, 
1994). Epidemiological studies have shown that a regular intake of soy foods is 
associated with a reduced risk of several chronic pathologies, such as coronary 
heart disease, cancer, (Setchell and Cassidy, 1999) and atherosclerosis, 
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associated with oxidative damage (Anthony et al., 1998; Hertog et al.,1998) .  
Different hypotheses have been suggested to explain these health benefits, such 
as the involvement of the two major isoflavones in soy foods, genistein and 
daidzein, whose different biological activities have been documented in vitro 
and in vivo studies. For example, it has been proposed that the protective effect 
exerted by genistein against atherosclerosis could be related to its antioxidant 
properties (Ferretti et al., 2003); in fact, genistein is able to inhibit lipid 
peroxidation induced in vitro by several pro-oxidant agents on model and 
natural membranes (Jha et al., 1985), on cultured cells (Guo et al., 2002; Ho et 
al.,2003), and on low density lipoproteins (LDL) (Kerry et al., 1998; Wilson et 
al., 2002).  
On the other hand,  it has been reported, for example, that genistein can impact 
negatively  the growth performance. This happen if, considering that a 
maximum concentration of genistein in soy products is ~ 5900 µg/g, this is 
added to a concentration  of 3000µg/g of genistein, which is more or less equal 
to genistein levels when there is a total replacement of fish meal by soybean 
meal (Chen et al., 2014). So, it has been observed that the high dietary levels of 
genistein (3000 µg/g) can depress the growth performance in fishes, as Nile 
Tilapia, while lower levels of it (0-300µg/g) haven’t effect on growth 
performance (Chen et al., 2014); similar results have also been reported  in 
rainbow trout (Oncorhynchus mykiss) (Catherine et al., 2001) for a dietary 
genistein supplementation of 500µg/g. Here, this suppressing effect of genistein 
can be partly due to its capacity of  inhibit the activity of major digestive 
enzymes: stomach protease and intestine amylase. In vivo and in vitro studies 
indicate genistein (and dadzein) is capable of binding to and activating estrogen 
receptors in rainbow trout (Latonnelle et al., 2000; Bennetau-Pelissero et al., 
2001; Denny et al., 2005; Cosnefroy et al., 2009; Cleveland, 2014 ). This ability 
suggests that they may have negative effects on growth- related mechanisms 
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that are parallel to those of estradiol. In fact, in salmonids E2 negatively affects 
physiological and metabolic processes that support anabolic growth, as down- 
regulating  the growth hormone (GH)/insulin-like growth factor (IGF) axis 
(Holloway and Leatherland, 1998; Norbeck and Sheridan, 2011), and promoting 
catabolic effects on protein turnover in skeletal muscle (reducing rates of 
protein synthesis and increasing rates of protein degradation). Cleveland and 
Weber, in 2011, demonstrated that also phytoestrogens (as genistein) are 
capable of these effects. For example, phytoestrogens have effects on protein 
turnover and cell proliferation in rainbow trout white muscle, in particular, high 
concentrations of these have negative effects on skeletal growth via estrogen 
receptor-dependent and –independent mechanisms (Cleveland, 2014). Many 
studies have been done on the effects that phytoestrogens can have on metabolic 
processes in mammals, as on lipid metabolism and glucose tolerance,  through 
estrogen receptor-dependent and  -independent mechanisms, the latter including 
AMPK and PPAR activation and inhibition of tyrosine kinase activity (Orgaard 
and Jensen, 2008; Arunkumar and Anuradha, 2012; Palacios-Gonzalez et al., 
2014). But few of these studies have been done on the effects of phytoestrogens 
and their mechanisms of action in fish adipose tissue. 
Thus, in this study we want to examine the in vivo effects of  the phytoestrogen, 
genistein, on lipid metabolism in adipose tissue primarily, but also in liver and 
white muscle, and its in vitro effects on adipocytes in culture from rainbow trout 
(Oncorhynchus mykiss). In addition, in vivo effects of genistein on apoptosis- 
related genes expression and autophagy-related genes expression in all three 






1.1 Oncorhynchus mikyss (common name “Rainbow trout”) 
 
1.1.1 Taxonomy 
Class: Actinopterygii  
Order: Salmoniformes  
Family: Salmonidae  
Genre: Oncorhynchus  





The rainbow trout has an elongate body, the length of which is generally 5 times 
greater than its height. The head has a conical shape and the mouth is slightly 
oblique, with the maxillary bone which extends to the posterior edge of the eye. 
The trout teeth are arranged in 1 or 2 series and are present only on the stem of 
the ploughshare. The lateral line is nearly horizontal and back, before the tail 
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fin, is an adipose fin with a black edge. There aren’t nuptial tubercles, but 
changes take place about the head, mouth and colour in spawning males. The 
body colour of the rainbow trout may vary according to habitat, the size of the 
specimens and their stage of sexual maturation. Generally the body of this 
salmonid has a green-blue shade into dorsal part, while the hip area shows a 
pigmentation which gradually tends to clear and take silvery reflections. On the 
sides there is a pink band along the lateral line which assumes more intense 
shades tending to iridescent when arrives the breeding season. The abdomen of 
the trout has further a colour lighter, almost whitish. 
 
1.1.3 Biology and habitat 
Rainbow trout is a species native to north America, that since 1874 it has been 
introduced in most of the rivers on the planet, for recreational fishery and 
aquaculture. This species has an anadromous life cycle, in fact, it spends a few 
years of life at sea, then, returns to freshwater when spawning begins. These 
animals are characterize by a very rapid growth and, are be able to, in just three 
years, accumulate from 7 to 10 kg of weigh, while normal rainbow trout, in the 
same time, increase by a maximum of 4.5kg. The rainbow trout was introduced 
in Italy about a century ago, and, as a result of its outstanding ability to adapt to 
various environmental conditions, the presence of this salmonid can be found in 
most of the rivers and lakes on the national territory, nowadays. It is a species 
that is easily reproduced in captivity, and, is characterized by very short rates of 
growth.  
Rainbow trout fry have dimensions greater than those of the majority fish 
species, and, this gives the possibility of being able to administer artificial diet 
during the early stages of breeding, so to abbreviate the weaning times. This 
species is very well suited to various temperature conditions and can survive in 
environments characterized by a temperature range between 0 and 27° C. The 
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growth of trout takes place in water temperatures that can vary from 6° to 20° C 
with a thermal optimum between 14° and 18° C , while as regards the 
reproductive activity , the optimal thermal levels are between 10° and 12°C.  
Usually, the maturation of sexual organs takes place on reaching the 3rd-4th 
year of age, but acting on the diet and thermal conditions of the environment, 
this can be anticipated. The eggs of the trout have a diameter ranging from 3 to 
7 mm, and, the females can also produce up to 2000 per kg of body weight. In 
breeding, changing some environmental parameters or through hormonal 
treatments depending on broodstock, it is possible to obtain only females or 
sterile individuals. These last show development similar to that of females, but 
more rapid than that of males. Spawning occurs in the natural environment  in 
spring (January-May), but in breeding, this stage can be moved in time, acting 
on nutrition, on the conditions of photoperiod or through hormonal induction.  
In the wild, adult trout feed on aquatic and terrestrial insects, molluscs, 
crustaceans, fish eggs, minnows, and other small fishes, but the most important 
food is freshwater shrimp, containing the carotenoid pigments responsible for 
the orange-pink colour in the flesh. In aquaculture, the inclusion of the synthetic 
pigments astaxanthin and canthaxanthin in aquafeeds causes this pink 




Fig. 1 Production cycle of Oncorhynchus mykiss. 
 
1.1.4 Farm techniques  
The breeding of the trout is generally practiced within intensive structure, in 
which it must constantly be the opportunity to take advantage of waters of 
excellent quality (without aeration - 1 l/min/kg of trout without aeration or 5 
l/sec/tonne of trout with aeration), that meets a number of criteria: 
DO2: near saturation. 
CO2: <2.0 ppm. 
Temperature: 12-21ºC. 
pH: 6.5-8.5. 
Alkalinity (as CaCO3): 10-400 mg/litre. 
Manganese: <0.01 mg/litre. 
Iron: <1.0 mg/litre. 
Zinc: <0.05 mg/litre. 




Trout is very sensitive to the presence of nitrogenous substances which are 
derived from the catabolism of proteins, such as , ammonia, nitrates and nitrites. 
A parameter that must always be kept under control in the plants of trout 
farming that use water (with dissolved nitrogen) pumped from underground 
wells , is the oversaturation gaseous water, which must be avoided because it 
causes the formation of gas bubbles in the blood of the fish. Alternatively, river 
water can be used, but temperature and flow fluctuations alter production 
capacity. Trout are animals that can tolerate an higher alkalinity and hardness of 
water compared to acidity, but in any case, it is good practice to use neutral or 
medially alkaline water with a pH between 6.5 and 8.5. However, when the 
above criteria are met, trout are generally on-grown in raceways or ponds 
supplied with flowing water, but some are produced in cages and recirculating 
systems. 
1.1.5 Fry production 
Trout will not spawn naturally in culture systems; thus juveniles must be 
obtained either by artificial spawning in a hatchery or by collecting eggs from 
wild stocks. Larvae are well developed at hatching. The breeders, males and 
females, after being selected, are generally kept separate. The choice of their 
number depends on the number of fry required, and, the ratio which is most 
frequently adopted between males and females is 1:3. The females don’t spawn 
naturally in captivity environment, and when are fully mature, to induce  the 
release of the eggs, it is necessary human intervention. Trout are subjected to an 
anesthetic treatment, and subsequently, eggs are removed manually from 
females by applying a slight pressure on the abdomen  from the pelvic fins to 
the vent area. To reduce the stress of the animals, it has been ideated another 
method of extraction, “air  spawning” ; it consists of insertion of a hypodermic 
needle about 10 mm into the body cavity near the pelvic fins and air pressure (2 
psi) expels the eggs. The air is removed from the body cavity by massaging the 
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sides of the fish. Up to 2000 eggs/kg body weight are collected in a dry pan and 
kept dry, improving fertilization. Males are stripped in the same way as females; 
the semen is collected into containers by pressing, and then, added to eggs.  
Water is added to activate the sperm and allow the eggs to increase in size by 
about  20 percent by filling the perivitelline space between the shell and yoke; a 
process known as 'water-hardening'.  
Fertilized eggs are incubated in hatcheries until the eyed stage is reached; the 
others (non-viable eggs) are removed. A single water source flows (3-4 L/min) 
up through the eggs, spills over into the tray below, thus becoming aerated, 
allowing large numbers of eggs to hatch in a minimal amount of space and 
water. Time required to hatch varies according to the water temperature. With a 
temperature of 3.9°C it takes 100 days , while with 14.4°C requires 21 days, for 
a total of about 370 degrees/day. Fry can remain in trays until swim-up at about 
10 to 14 days after hatching. Hatching of the batch of eggs usually takes 2-3 
days, during which time all eggshells are regularly removed, as well as dead and 
deformed fry. Eggs incubated separately from rearing troughs are transferred to 
rearing troughs after hatching.  
After hatching, the trays are removed and trough water depth is kept shallow (8-
10 cm) with a reduced flow until fry reach 'swim-up' stage, the yolk sac is 
absorbed, and active food searching . Larvae are able to absorb the yolk sac in a 
period ranging from 2 to 6 weeks , depending on the temperature conditions, 
and, when the yolk sac has been absorbed for about 2/3, begins the artificial 
administration of food with frequent meals and diets properly formulated. In 
these rearing troughs, feed pellets, made of fish meal (80 percent), fish oils and 
grains, provide nutritional balance, encouraging growth and product quality, and 
are formulated to contain approximately 50 percent protein, 12-15 percent fat, 
vitamins (A, D and E), minerals (calcium, phosphorus and sodium) and a 
pigment to achieve pink flesh (where desirable). In this phase, it is very 
 
15 
important the efficiency of the water exchange; in case of poor availability of 
water, it is appropriate to reduce the loading of the animals in the tanks up to 10 
kg / m3, so as to ensure at least 6 changes of water per day. 
During this period and also in the subsequent phases, it is extremely important 
to calibrate fishes to form groups of uniform size, to facilitate the management, 
and, to reduce losses due to cannibalism. Fry remain in these tanks until the 
completion of ossification of cartilaginous tissues, which usually occurs around 
the 12th week of life. 
1.1.6 Fattening techniques-intensive farming 
When fry reach 8-10 cm in length (250 fish/kg), they are transferred into 
fattening facilities, as concrete raceways, ponds or cages. The raceways are the 
most used in the traditional trout farming, which, usually, are rectangular tanks 
2-3 m wide, 12-30 m long and 1-1.2 m deep. The amount of food that is given, 
the amount of water exchange, and, the amount of oxygen to add in the water 
body, will have to be appropriate to bred biomass and average size of trout. The 
sustainable load into tanks must be established as a function of environmental 
conditions and water temperature. The factor that has the greatest impact on 
growth of trout is the water temperature, which should never deviate too much 
from the optimal temperature levels. With temperatures between 10°C and 
14°C, the trout can reach a weight of 80-100g and a length of 15-20cm in only 
6-8 months after hatching, and using diets high in energy, they reach the size of 
commercialization (250-300 g) in 10-12 months. Alternative on-growing 
systems for trout include cage culture (6 m by 6 m by 4-5 m deep) production 
systems where fish (up to 100 000) are held in floating cages in freshwater and 
marine environments, ensuring good water supply and sufficient dissolved 
oxygen. This method uses existing water bodies at a lower capital cost than 
flow-through systems. However, on one hand, stocks are vulnerable to external 
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water quality problems and fish eating predators (rats and birds), and growth 
rates depend on ambient temperature; on the other, high stocking densities can 
be achieved (30-40 kg/m²) and fish transferred to marine cages have faster 
growth rates, reaching larger market size. Fry of about 70 g weight can attain 3 
kg in less than 18 months. 
1.1.7 Nutrition of farmed trout 
Feeds for rainbow trout have been modified over the years. Rainbow trout feeds 
have undergone a shift since the 1970s (fig. 2); in the same period, the 
percentage of digestible protein has increased, making modern trout feeds much 
more efficient and less polluting.  







An additional change in trout feeds has been a reduction of the percentage of 
protein provided by fishmeal and a corresponding increase in the contribution of 
alternate proteins, mainly plant protein concentrates and animal proteins, such 
as poultry byproduct meal. Another shift in formulation of rainbow trout feeds is 
replacement of fish oil with plant oils. In 2006, 88 percent of global production 
of fish oil was consumed in aquafeeds (Tacon and Metian, 2008); for this, in 
2006/2007, there was an increase of fish oil price that leads feed producers to 
replace portions of fish oil with plant oils such as rapeseed oil and soy bean oil.  
 Fig.2 Changes in percent   protein, digestible protein 
and fat in rainbow trout feed. (FAO) 
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About feed ingredients used in rainbow trout feed formulations, these are 
similar throughout the world; in Tab.2, are shown some examples of rainbow 
trout feed formulations: 
Ingredient composition 
(%) 
Life stages/ size class 
 Early fry Fry Fingerling Growe
r 
Broodstock 
Fish meal 68 68 46 30 34 
Corn gluten meal 0 0 2 4 4 
Poultry byproduct meal 2 2 5 6 8 
Feather meal 0 0 4 6 5 
Soybean meal 0 0 5 12 10 
Blood meal, avian 1 1 2 4 4 
Ground wheat 17 17 20 22 20 
Soybean oil 0 0 0 5 0 
Fish oil 10 10 12 9 10 
Vitamin 1.5 1.5 1.5 1.5 1.5 
Mineral 0.5 0.5 0.5 0.5 0.5 
Tab.2 Feed formulae (ingredient composition) of commonly used feed for different life 









1.1.8 Main producer countries 
Main areas where it is practiced aquaculture trout are located in Europe, North 
America, Chile, Japan and Australia. 
 
 
Fig. 3 Main producer countries of Oncorhynchus mykiss (FAO Fishery Statistics, 2006). 
 
 
1.2 Lipid metabolism in liver and adipose tissue  
 
1.2.1 An introduction to lipids 
The noun lipid refers to a large and heterogeneous group of substances 
classified together on the basis of their high solubility in non-polar solvents or 
their relatedness to such compounds. Most of the lipids in eukaryotes are 
derived from acetyl-CoA and belong to three major classes: straight chain fatty 
acids; branched, cyclic, and other specialized fatty acids; and polyprenoid 
compounds, including carotenoids and sterols and their derivatives. Lipids have 
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a number of major roles in all organisms. Perhaps most importantly, they are  
structural components of cell membranes and are essential for energy provision 
and storage. Lipids and fatty acids, along with proteins, are the major 
macronutrients for fish (Sargent et al., 2002). Fish seem not to have evolved 
efficient carbohydrate utilization systems in contrast to terrestrial vertebrates. 
So, carbohydrates are less important as nutrients (quantitatively) for most fish, 
suggesting that fish may satisfy structural carbohydrate and storage 
carbohydrate (glycogen) requirements principally by catabolizing amino acids 
(Cowey and Walton, 1989). The types of lipids that are most vital to energy 
metabolism are fatty acids and triglycerides. Fatty acids are the most commonly 
stored and circulating forms of energy, and triglycerides are the most  common 
non-toxic form of fatty acids. Fatty acids/triglycerides may originate from four 
sources (pool input): de  novo fatty acids synthesis, cytoplasmic triacylglycerol 
stores, fatty acids derived from triglycerides of lipoprotein remnants directly 
taken up by the liver, and plasma non-esterified fatty acids (NEFA) released by 
adipose tissue. The relative importance of these sources depends on species 
differences and on short- and long-term nutritional status and energy balance.  
Fatty acids and triglycerides may also be used in different ways (pool output). 
Triglycerides may accumulate in hepatocytes (while NEFA or activated forms 
of NEFA may not) unless NEFA are oxidized (more or less completely) or 
triglycerides are exported as constituents of very low density lipoproteins 
(VLDL). The triacylglycerol content of hepatocytes is regulated by the activity 
of cellular molecules that facilitates hepatic fatty acid uptake, fatty acid 
synthesis, and esterification (‘input’) and hepatic fatty acid oxidation and 
triacylglycerol export (output). Moreover, fatty acids regulate lipid metabolism 
by binding nuclear receptors that modulate gene transcription. Peroxisome 
proliferator-activated receptors (PPAR) are ligand binding transcription factors 
of the nuclear receptor superfamily, which includes receptors for steroids, 
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thyroids and retinoids (Han et al., 2007; Sertznig et al., 2007). Three types of 
PPAR have been identified (a, b, ɤ), each encoded by distinct genes and 
expressed differently in many parts of the body (Sertznig et al., 2007). They 
form heterodimers with the retinoid X receptor, and these complexes 
subsequently bind to a specific DNA sequence, the peroxisome proliferating 
response element (PPRE) that is located in the promoter region of PPAR target 
genes and modulates their transcription (Tachibana et al., 2008). Gender and 
stage of life cycle influence expression levels of all the PPARs in brown trout; 
estrogen appears to play an important role in differential expression of PPARs 
(Batista-Pinto et al., 2009). In rainbow trout adipose tissue, the gene 
transcriptional levels of PPARs change differentially with the nutritional status 
(Cruz-Garcia et al., 2015). As in mammals, it was found in fish that PPARɤ is 
highly expressed in adipose tissue and acts as a promoter of fat storage and 
adipocyte differentiation (Bouraoui et al., 2008; Cruz-Garcia et al., 2009; 
Albalat et al., 2007). In concordance with this, it was seen that insulin 
administration upregulated this PPAR isotype highly significantly in trout 
adipose tissue in vivo and in in vitro in line with the pro-lipogenic actions of this 
hormone (Cruz-Garcia et al., 2015). PPARɤ gene expression increased during 
adipocyte differentiation in rainbow trout (Bouraoui et al., 2008), but not with 
differentiation of trout myocytes, in agreement with the myogenic development 
program (Rescan, 2008). PPARα and PPARβ are regulated by a  transcriptional 
factor LXR (liver X receptor) in trout myocytes (Cruz-Garcia et al., 2011); 
PPARα is regulated by insulin in trout adipose tissue, not instead PPARβ (Cruz-
Garcia et al.,2015). PPARβ has a controversial role in fish as in mammals; it 
seems to mediate lipolytic effects in gilthead sea bream (Cruz-Garcia et al., 
2009). 
In mammals, PPARɤ is expressed strongly in adipose tissue and is a master 
regulator of adipocyte differentiation (Lehrke et al., 2005). In addition to its role 
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in adipogenesis, PPARɤ is an important transcriptional regulator of glucose and 
lipid metabolism, and is implicated in the regulation of insulin sensitivity, 
atherosclerosis, and inflammation (Lehrke et al., 2005; Semple et al., 2006). 
PPARγ affects transcription rates of a variety of lipogenic target genes such as 
FABP4 (fatty acid binding protein 4), CD36 (thrombospondin receptor), LPL 
(lipoprotein lipase), leptin, ACC (Acetyl-CoA carboxylase), FAS (fatty acid 
synthase), and SCD1 (Stearoyl-CoA desaturase 1) (Lee and Hossner, 2002). 
Additionally, PPARα is responsible for regulating fatty acid β-oxidation (Varga 
et al., 2011).  Regarding PPARβ, little is known about it in the context of target 
tissues, target genes, lipid homeostasis, and functional overlap with PPARα, and 
PPARɤ. The activation of PPARβ in skeletal muscle cells programs a cascade of 
gene expression designed to activate catabolism, and energy expenditure 
(Dressel, et al., 2003). In adipose tissue, instead,  even if  PPARβ is not directly 
implicated in the control of adipogenesis, because alone  is not able to promote 
lipogenesis (but only together with PPARɤ), however, it plays a role in the 
adaptive response of adipose tissue to dietary fatty acid content, (Neels and 
Grimaldi, 2014). 
Definitely, fatty acids can be produced from acetyl CoA into “de novo” 
Lipogenesis, and can be broken down to acetyl CoA by β-oxidation, a cyclical 
pathway. Triglycerides, instead, accounted as the main storage form of fatty 
acids, are produced through the process known as Lipogenesis or synthesis of 
TG, while their hydrolysis is known as Lipolysis, with release of fatty acids. 
1.2.2 Hormonal regulation of lipid metabolism and its dependence on diet. 
Adipose tissue is a specialized organ that functions as one of the major storage 
sites for fat in the form of triglycerides and provides a buffer for energy 
imbalances. In mammals, the equilibrium between lipolytic and lipogenic 
pathways in adipose tissue is influenced by nutritional and endocrine factors 
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and by components of the immune response (Rosen et al., 2006). There is 
limited knowledge on the hormonal control of lipid turnover in fish adipose 
tissue (Albalat et al., 2005; Polakof et al., 2011). It has been seen that in 
mammals, GH reduces body fat, inhibits adipocyte differentiation, decreases 
lipogenesis, and increases lipolysis (Herrington et al.,2001; Xu et al., 2009). 
Also in isolated trout adipocytes, GH enhances lipolysis and inhibits, at least in 
part, lipogenesis. In the first case, through the direct  modulation of HSL 
activity probably, not at a transcriptional level; in the second, through the down-
regulation of FAS expression during fasting (Cruz-Garcia et al., 2015). It has 
been reported that growth hormone (GH), in addition to being a growth 
promoter, exerts a lipolytic effect in gilthead sea bream adipocytes too (Albalat 
et al., 2005; Salmeron et al., 2013). GH transgenic coho salmon (Leggatt et al., 
2009) are shown to increase their utilization of lipids for synthetic roles to 
maintain accelerated growth, but the specific effects in adipose tissue of GH 
overexpression remain unknown.  
Insulin acts as a promoter of carbohydrate and lipid deposition by reservoir 
tissues during the post-feeding period in fish, although its concentration 
decreases during fasting periods (Navarro et al., 2004), with an increase in 
circulating GH (Cruz-Garcia et al., 2015). During fasting, insulin down-
regulates PPARα expression, suggesting a reduction in fatty acids oxidation 
associated with the enhanced use of fatty acids for re-esterification and 
triglyceride synthesis. Studies have demonstrated the anabolic role of insulin in 
rainbow trout adipocytes and myocytes, where it stimulates glucose and fatty 
acid uptake (Capilla et al., 2004; Sanchez-Gurmachez et al., 2010). Insulin also 
stimulates lipoprotein lipase (LPL) activity in rainbow trout adipose tissue 
(Albalat et al., 2006) and reduces the basal lipolysis level in rainbow trout and 
gilthead sea bream adipocytes (Albalat et al., 2005; Albalat et al., 2005). 
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Insulin-like growth factor (IGF)-I is structurally and functionally similar to 
insulin but is more potent as a growth factor and a metabolic controller in 
rainbow trout and gilthead sea bream myocytes and adipocytes (Salmeròn et al., 
2013; Bouraoui et al., 2010; Codina et al., 2008; Castillo et al., 2004). In 
vertebrates, many of the growth-promoting actions of GH are known to be 
mediated indirectly through the stimulation of IGF transcription, mainly by the 
liver, or locally by extra hepatic tissues (Chia, 2014), but the mechanisms of 
action involved in GH proliferative and metabolic effects in fish are not well 
known (Bergan et al., 2013). 
In contrast, tumor necrosis factor a (TNFα), secreted by adipose tissue, that a 
part from acts as a pro-inflammatory cytokine, it also regulates lipid cell uptake 
and degradation of triglycerides because it is lipolytic in fish and mammalian 
adipose tissue (Saera-Vila et al., 2007; Albalat et al., 2005; Zhang et al., 2002). 
TNFα has been described as a limiting factor for adiposity in gilthead sea bream 
(Bouraoui et al., 2008; Saera-Vila et al., 2007), and it has been shown to 
promote lipolysis in isolated adipocytes of rainbow trout and gilthead sea bream 
(Albalat et al., 2005; Cruz-Garcia et al., 2009). The mechanisms underlying the 
action of TNFa on lipolysis are complex, and modulation of the expression of 
peroxisome proliferator-activated receptors (PPARs) appears to be significant 
(Cruz-Garcia et al., 2009). In fact, it has been reported by Cruz-Garcia that 
TNFα decreases PPARɤ expression in adipocytes in line with its anti-fat storage 
effects and anti-insulin actions described in relation to the lipid metabolism of 
mammals and fish (Bou et al., 2015; Nieto-Vazquez et al., 2008). Regarding 
PPARα expression after TNFα treatment in isolated cells, it remains to be 
elucidated, but points to a possible pathway for the inhibition of fatty acid 
oxidation in adipose tissue. 
The management of fat deposition has become a key area of interest in fish 
farming in the quest to obtain a high-quality product with good nutritional value 
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and to maintain fish health. Regarding the growth in fin-fish aquaculture, it has 
been made possible by the  development of artificial diets or feeds formulated to 
satisfy essential  requirements (amino acids, fatty acids, vitamins and minerals, 
etc.), and provide macronutrients (protein, lipid, carbohydrate) and energy in 
balance to optimize growth. Thus, it has been the requirements of aquaculture 
that have driven research into fish nutrition, including lipid and fatty acid 
metabolism and its regulation. Dietary lipid and fatty acids can have three 
primary fates in fish. They can be incorporated into cell membranes and hence 
the flesh of the fish, they can be oxidized to provide energy, or lipid can be 
deposited in adipose or other tissues as energy storage (Tocher, 2003). 
Therefore, from an aquaculture perspective, the lipid (fat) content and the fatty 
acid composition of the diet must be optimized to enable high growth rates, 
ensure fish health, and, at the same time, maintain the nutritional benefits of fish 
for the human consumer (Sargent et al., 2002; Tocher, 2003). The lipid content 
of pelleted diets has increased greatly in recent years due in part to the technical 
advancements in the production of feed. This increase is driven by the 
observation that more energy can be supplied by dietary lipid,  less protein will 
be used for energy, and so  more dietary protein can be “spared” for synthesis of 
new tissue/flesh (Hemre and Sandnes, 1999). However, although protein 
sparing by dietary lipid is widely accepted, the limits to its effectiveness, or the 
mechanisms by which it might occur, have not been accurately defined for any 
fish (see Company et al., 1999). Consequently, dietary formulations have 
maximized lipid content in order to satisfy commercial pressure to increase 
growth rates and reduce production times, despite the fact that there is a strong 
relationship between dietary lipid levels and undesirable levels of lipid in the 
carcass of fish (Cowey and Cho, 1993). In fact, the administration of high-lipid 
feed can lead to an unwanted increase in fat deposition that alters sensory and 
organoleptic characteristics (Kjaer et al., 2008; Turchini et al., 2009). In 
addition, because of fatty acid composition of fish lipids generally reflects the 
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fatty acid profile of  the diets (Watanabe, 1982), studies have been conducted 
into the lipid metabolic disorders associated with the content and type of lipids 
in the diet (Turchini et al., 2009; Benedito-Palos et al., 2008) and the dietary 
effects on macrophage function and stress susceptibility (Sitjà-Bobadilla et 
al.,2005;Gjoen et al.,2004). Unfortunately, while  in higher vertebrates, many  
studies have shown that changes in dietary fatty acid composition can induce 
modification of hepatic lipogenesis (Blake & Clarke,1990; Clarke et al. 1990, 
Salati & Amir-Ahmady, 2001), lipid transport in blood (Grundy & Denke, 
1990; Fernandez & West, 2005) and tissue lipid uptake (Montalto & 
Bensadoun, 1993; Raclot et al., 1997), a few of them have been done on fishes 
as on rainbow trout. One of these studies on rainbow trout, conducted by 
Richard  et al., in 2006, has shown that a dietary vegetable oils can have a little 
effects on hepatic lipogenesis, lipid transport and tissue lipid uptake; in 
particular, it was seen that hepatic lipogenesis and lipid uptake in perivisceral 
adipose tissue, white muscle and liver weren’t modified; only regarding the 
lipid composition of plasma, it was seen a decrease in plasma cholesterol and 
LDL (low density lipoproteins), because of  expression of LDL receptor  gene 
in the liver that was down-regulated. 
1.2.3 Fatty acids synthesis and uptake 
Two major tissues produce fatty acids in the body: the liver and the adipose 
tissue. Fatty acids synthesized in the liver are exported through lipoprotein 
production, and thus provide an energy source and structural components for 
membrane building. In adipose tissue, de novo synthesis of fatty acid directly 
contributes to in situ fat deposition and long-term energy storage. Fatty acids 
synthesis occurs in the cytosol and uses acetyl CoA to build a long chain fatty 
acid.  As shown in fig.4, the first step of fatty acids synthesis consists in a 
conversion of two-carbon acetyl CoA into a three-carbon malonyl CoA (the 
substrate of the multiprotein enzyme fatty acid synthase), this thanks to an 
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enzyme, acetyl CoA carboxylase. Fatty acids synthase uses malonyl CoA (and 
reducing energy of NADPH) to extend the length of the fatty acid, adding two 
carbons in a series of four reactions: 1) condensation, 2) reduction, 3) 
dehydration, 4) reduction. At the end of one cycle (5), the fatty acid shifts to the 
initial position to allow the next malonyl CoA to bind. After seven cycles, when 
the fatty acid has grown to 16 carbons, palmitate has been produced; this is a 
common component of fatty acid stores and from it can be produced fatty acids 
with longer chains. (Fig. 4).  
 
Besides the synthesis capacity of adipose tissue and liver,  these tissues take up 
NEFA from the blood in proportion to their concentration. NEFA enter cells via 
transporters (fatty acid transport protein (FATP) or fatty acid translocase (FAT)) 
or diffusion. Into cells, long-chain fatty acids of 14 carbons or more are 
covalently bound and activated by fatty acid binding protein (FABP) or acyl-
CoA synthetases (ACS) found in the microsomes and outer mitochondrial 
membrane. These transport fatty acids to intracellular compartments (for 
metabolism) or the cellular nucleus (to interact with transcription factors). 




However the cells with these fatty acids, rapidly, assimilate them into neutral 
and polar lipids, and some are oxidized. The result of these metabolic pathways 
is to keep intracellular NEFA and fatty acyl-CoA very low. 
1.2.4 Β-oxidation of fatty acids 
The catabolism of fatty acids can occur by β-oxidation in two different 
organelles in the cells, mitochondria and peroxisomes. Red muscle, liver, and 
heart are generally regarded as the most important tissues for β-oxidation in 
fish. The fatty acid oxidation pathway happens primarily into mitochondria and 
results in the production of acetyl CoA. Depending on conditions, this acetyl-  
CoA can enter the TCA cycle or be destined to other pathways. Because the 
substrate for β-oxidation is fatty acyl CoA, cells must first convert fatty acids to 
their CoA esters using a fatty acyl CoA synthase. While short and medium 
chain fatty acids are able to enter the mitochondria directly (where they are 
activated by a mitochondrial fatty acyl CoA synthase), Palmitate (and others as 
it) that cannot cross outer mitochondrial membrane, is activated by an 
extramitochondrial fatty acyl CoA synthase. Because mitochondria aren’t able 
to import any fatty acyl CoA directly, they use a multienzyme complex ( known 




as carnitine palmitoyl transferase, CPT) and this transport process is called the 
“carnitine shuttle” (Fig.5). After that fatty acyl CoA has crossed the outer 
mitochondrial membrane, is converted to fatty acyl carnitine by the enzyme 
CPT-1 releasing coenzyme A (CoASH). After that fatty acyl carnitine is 
transported across the inner mitochondrial membrane by the carnitine-acyl 
carnitine translocase, the enzyme CPT-2 
converts it into fatty acyl CoA. This 
elaborate transport process provides an 
additional level of control for the 
oxidation of long chain fatty acids as 
Palmitate. Once inside the mitochondria, 
fatty acids enter the β-oxidation pathway 
(Fig.6). This is a cyclical  pathway that 
sequentially cuts pairs of carbons of fatty 
acid to form acetyl CoA. Β- oxidation 











Fig.6 Fatty acid oxidation. (Animal 
Physiolology, Moyes and Schulte, 2006).  
 
29 
This cycle is repeated until  all the acyl CoA of the fatty acid are converted to 
acetyl CoA. 
1. The first step provides a dehydrogenation of the fatty acyl CoA (a loss of 
hydrogen), forming double bind between carbon 1 and carbon 2 of the  
molecule; this reaction is catalysed by enzyme acyl CoA dehydrogenase 
(present on mitochondrial inner membrane) that uses as coenzyme FAD 
that, in turn, gaining the hydrogen atoms dissociated, become FADH2. 
The oxidation reaction is the following: 
          Fatty acyl CoA     acyl CoA dehydrogenase         Enoyl CoA + FADH2 
2. The second step is a reaction of hydration catalyzed by the enzyme Enoyl 
CoA hydratase, with the addition of a H2O molecule to double bind 
formed to have β-hydroxyl CoA, according to this reaction: 
 
Enoyl CoA  β-hydroxyl CoA 
                              H2O 
 
3. The third step is an another oxidation reaction catalyzed by enzyme β-
hydroxyacyl dehydrogenase that has as co-factor NAD
+
; this reaction of 
dehydrogenation provides a transformation of the hydroxyl group on the 
C3 into a carbonyl group, with the loss of two hydrogen atoms, one of 
which is gained by NAD
+
 that become, in turn, NADH according to the 
following reaction: 
Β-hydroxyl CoA    β-hydroxyacyl dehydrogenase         β-ketoacyl CoA 
 
4. The last step is a thiolysis reaction that provides a separation of the 
remaining carbonyl group; it is catalyzed by an enzyme thiolase that uses 
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as co-enzyme CoASH which, in turn, acts as lytic agent to form an acetyl 
CoA plus a fatty acyl CoA, following the reaction: 
 
β-ketoacyl CoA         thiolase                Acyl CoA + Acetyl CoA  
                          CoASH 
 
About 30% of the energy liberated from fatty acids derives from reducing  
equivalents (FAD and NAD
+
) produced in β-oxidation. The remaining 70% 
derives, instead, from oxidation of acetyl CoA in the TCA cycle (citric acid 
cycle, also known as Krebs cycle). Mitochondrial β-oxidation isn’t the only 
pathway trough which it happens fatty acids breakdown, but many cells have 
other pathways that are complementary to the mitochondrial. In the 
peroxisomes occurs a β-oxidation that processes very long chain fatty acids 
(more than 22 carbons), which aren’t efficiently oxidized in the mitochondrial 
pathway; this process occurs through a few cycles, releasing the shortened fatty 
acids into the cytoplasm where they can be oxidized by mitochondrial β-
oxidation. A third pathway of fatty acid oxidation is called ω-oxidation and 
occurs in the endoplasmic reticulum of liver and kidney. However, this process 
isn’t important for the production of energy but can used in order to synthetize 
other metabolites.  
 
1.2.5 Lipogenesis 
A triglyceride is an ester composed of glycerol and three fatty acids. A lot of 
tissues can produce triglyceride from fatty acids for a long-term storage of this 
metabolic fuel. The tissues that act as lipid storage tissues, producing o 
releasing fatty acids on behalf of other tissues, are adipose tissue and liver in 
vertebrates. About liver, it has been seen that species with limited hepatic 
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lipogenesis have less ability to secrete 
triacylglycerol from the liver compared with 
species in which the liver is a major or 
moderate source of lipogenesis (Pullen et al., 
1990). In these species, fatty acids could 
preferentially be esterified into phospholipids 
that would be incorporated into membranes, 
then transferred to pre-high-density lipoprotein 
particles (Yokoyama, 2006). However, in 
some cases, the liver can also synthesize 
triglycerides when high concentrations of 
NEFA are present and phospholipid transfer to 
membranes is exceeded. Triglyceride 
synthesis, or lipogenesis, is a multistep 
pathway through which from glycerol 3-
phosphate (produced from glycolysis), fatty 
acids (activated into their CoA ester by fatty 
acyl CoA synthase) are added sequentially to 
carbon 1 then carbon 2 to form phosphatidic 
acid; after removal of the phosphate group, 1,2-diacylglicerol is formed. At the 
end with the addition of a third fatty acid, triglyceride is formed (Fig.7). 
Triacylglycerol synthesis is under the control of transcription factors and 
nuclear receptors such as sterol regulatory element binding proteins SREBP-1c, 
carbohydrate regulatory element binding protein (ChREBP) (Dentin et al., 
2006), peroxisome proliferator-activated receptor c (PPARɤ), liver X receptors 
(LXRs) and their ligands. These play an important role together with hormonal 
and nutritional regulators, such as insulin, carbohydrate, and fatty acids 
(Coleman and Lee, 2004). 
Fig.7 Triglyceride synthesis. (Animal 




1.2.6 Triglyceride export (VLDL synthesis and secretion) 
The liver synthetize VLDL (very low density lipoproteins), enclosing inside 
them a large amount of triglycerides. VLDL are lipoproteins that, like the other 
(chylomicrons, IDL, LDL, HDL), are constituted of a central core with lipids 
inside, and an outer shell constituted of one or more apoproteins, phospholipids 
with polar groups on the outside and free cholesterol; but, differ from the other 
lipoproteins in lipid composition and apoproteins, which subserve both the lipid 
transport (allowing them to move in the aqueous smoothly), and the regulation 
of lipoproteins metabolism, through interaction with plasma enzymes and with 
specific cellular receptors.  In particular, chylomicrons provide the transport of 
exogenous lipids from the intestine to the tissues; LDL and HDL are 
characterized by an high content in cholesterol, carrying it into blood; but, while 
the first give it to the tissues, the latter, instead, remove superfluous cholesterol 
from pheripheral tissues and transport it to the liver.  
VLDL, synthetized into liver, transport endogenous triglycerides  from liver to 
the tissues. Apoprotein B100 (apoB100; and apoB48 in a few species) is the key 
component whose rate of synthesis in the rough endoplasmic reticulum controls 
the overall rate of VLDL production. Lipid components that are synthesized in 
the smooth endoplasmic reticulum are added by the microsomal triacylglycerol 
transfer protein to apoprotein B (White et al., 1998). After being carried to the 
Golgi apparatus in transport vesicles, the apoproteins are glycosylated. 
Secretory vesicles bud off the Golgi membrane, migrate to the  membrane of the 
hepatocyte, then fuse with the membrane and release the VLDL into blood , 
through which , the latter come to pheripheral tissues, as muscle or adipose 
tissue, where release triglycerides transported. After they have given a good part 
of  triglycerides to the tissues, their density and content in cholesterol increase, 
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so, firstly, become IDL (intermediate density lipoprotein), then, losing 
triglycerides again, LDL (low density lipoprotein). There are important species 
differences in the ability to export triglycerides from the liver as VLDL despite 
similar rates of esterification of fatty acids to triglycerides. It has been 
suggested that among different species, the rate of export of triglycerides as 
VLDL from the liver is proportional to its lipogenic capacity. For example, 
some animals that don’t synthetize fatty acids in the liver also have low rates of 
triglycerides export from the liver, with an increased risk of fat accumulation in 
this tissue; instead, others, in which lipogenesis occurs predominantly in the 
liver (chicken and fish), or in adipose tissue and liver (rabbits and rats) produce 
very high/intermediate rates of VLDL (Pullen et al., 1990). The origin of the 
fatty acids, that constitute triglycerides, can affect the rate of VLDL export. In 
obese mice, de novo fatty acids synthesis in the liver does not stimulate VLDL 
production (Wiegman et al., 2003). Rather, plasma exogenous NEFA, seem to 
play an important role in enhancing hepatic esterification and stimulating VLDL 
production (Julius, 2003), as it has been seen in rats. 
 
1.2.7 Lipolysis 
Triglyceride breakdown, or lipolysis, needs enzymes called lipases that attack 
triglyceride molecule, breaking the bond between the fatty acid and glycerol. 
There are two types of lipases, an hormone-sensitive lipase (HSL) that breaks 
off two fatty acid from triglyceride molecule to form diacylglyceride, and, 
monocylglyceride lipase that completes the breakdown of triglyceride, releasing 
the last fatty acid and separating it from glycerol. The liberated fatty acids are 
either used directly into the cell or introduced into circulation for uptake by 




1.2.8 Adipose tissue and “Adipogenesis” 
The mesenteric adipose tissue is an organ of fat accumulation in fish which, 
together with the muscle and liver, controls the lipid homeostasis and energetic 
balance of the animal (Jobling and Johansen, 2003; Sheridan and Kao, 1998), 
and, at the same time, it also acts as an endocrine organ secreting adipokines 
which act as potent messengers to distant organs such as the liver and muscle to 
maintain the body's energy balance (Gregor and Hotamisligil, 2007).   
Adipose tissue stores lipids and provides energy from lipid stores. Triglycerides,  
which come from the diet, are hydrolyzed by lipoprotein lipase (LPL) and the  
fatty acids released are taken up by the adipocytes and accumulated in droplet 
form. In response to energy demands, (HSL), after  phosphorylation by protein  
kinase A, can access the lipid droplet  and hydrolyze the triglycerides into 
glycerol and fatty acids (Lafontan and Langin, 2009).In fish as in mammals, the 
development of adipose tissue is a continuous process which includes the 
hypertrophy of existing adipocytes and the proliferation of new ones. The 
training process of new adipocytes from undifferentiated mesenchymal cells is 
called adipogenesis (fig.8); this occurs thanks to a transcriptional factor PPARɤ 
(Peroxisome Proliferator Activated Receptor gamma,), that activates other 
transcriptional factors, and by which, the precursor cells become lipoblast, and 
then, pre-adipocytes; the latter, then, proliferate and differentiate into 









These processes are known to be affected by diet in mammals, but how dietary  
changes affect the capacity for enlargement of adipocytes or the  differentiation  
of new ones is poorly understood in fish. For example, it was seen by Cruz-
Garcia et al. in a study conducted in 2011 on gilthead sea bream (Sparus Aurata 
L.) that fish oil substitution by 66% vegetable oils in a diet results in an increase 
of lipolytic activity and adipocyte cell size. Therefore, dietary vegetable oil, 
causing changes in tissue fatty acids composition, can affect the metabolism of 
gilthead sea bream adipocytes and the proliferation of new cells which could 
potentially affect other organs such as the liver. It has been suggested that 
excessive lipid accumulation in the liver or steatosis is due in part to the 
increased hepatic uptake of fatty acids released from adipose tissue with 
enhanced lipolysis (Benedito-Palos et al., 2008).  
 
1.2.9 The adipocyte life cycle 
Adipocytes are derived from mesenchymal stem cells, which have the potential 
to differentiate into myoblasts, chondroblasts, osteoblasts or adipocytes. The 
adipocyte life cycle includes alteration of cell shape and growth arrest, clonal 
storage of lipid and finally cell death (Gregoire, 2001) (fig. 9). During the  
growth phase, preadipocytes resemble fibroblasts morphologically. Pref-1, a  
Preadipocytes Mature 
adipocytes 
Day 0 Day 7 Day 10 
    Confluence 
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preadipocyte-secreted factor serves as a marker for preadipocytes and is 
extinguished during adipocyte differentiation (Wang, et al., 2006). At 
confluence, preadipocytes enter a resting phase called growth arrest before 
undergoing the differentiation process. Two transcription factors, 
CCAAT/enhancer binding protein (C/EBPα), and peroxisome proliferator-
activated receptor PPARγ were shown to be  involved in the preadipocyte 
growth arrest that is required for adipocyte  differentiation (Umek, et al., 1991). 
Following growth arrest, preadipocytes must receive an appropriate 
combination of mitogenic and adipogenic signals to continue through the 
subsequent differentiation steps. During the process of differentiation, 
preadipocytes undergo one round of DNA replication leading to clonal 
amplification of committed cells (Pairault, et al., 1979). The induction of 
differentiation also results in drastic change in cell shape as the cells convert 
from fibroblastic to spherical shape. Following induction, a dramatic decrease in 
Pref-1 expression accompanies a rapid increase in the expression of C/EBPβ, 
followed by expression of C/EBPα and PPARγ (Rosen, et al., 2002). During the 
terminal stages of differentiation, the mRNA levels for enzymes involved in 
triacylglycerol metabolism like glycerol-3-phosphate dehydrogenase, fatty acid 
synthase and glyceraldehyde-3-phosphate dehydrogenase, increase to a great 
extent (Paulauskis, et al., 1988; Spiegelman, et al., 1983). Finally, the total 
number of adipocytes change throughout life, and new adipocytes can be 






Fig.9 Mesenchymal stem cells are the precursors of several different types of cells, 
including myoblasts, chondroblasts, osteoblasts and preadipocytes. Once preadipocytes 
are triggered to mature, they begin to change shape and undergo a round of cell 
division known as clonal expansion, followed by initiation of the genetic program that 
allows them to synthesize and store triglycerides. Mature adipocytes can continue 
storing lipid when energy intake exceeds output, and they can mobilize and oxidize lipid 
when energy output exceeds input. Mature adipocytes can also undergo apoptotic cell 
death under certain conditions. 
 
1.3 Apoptosis and autophagy 
Cell death has been subdivided into the categories apoptosis (Type I), 
autophagic cell death (Type II), and necrosis (Type III). The boundary between 
Type I and II has never been completely clear and perhaps does not exist due to 
intrinsic factors among different cell types and the crosstalk among organelles 
within each type. Apoptosis can begin with autophagy, autophagy can end with 
apoptosis, and blockage of caspase activity can cause a cell to default to Type II 




 Fig.9 Types of cell deaths. (Richard A. Lockshin and Zahra Zakeri, 2004) 
The controlled cells deaths frequently display substantial caspase-independent 
autophagy or they are predominantly apoptotic. Most apoptotic deaths are 
caspase-dependent, but there are claims of apoptotic morphology in situations in 
which caspase activity is equivocal. Caspase activation can occur by means of 
ligation of a membrane-bound receptor or by means of metabolic changes 
resulting in depolarization of mitochondria and release of cytochrome c and 
APAF-1. Other metabolic means of activating apoptosis include UPR (unfolded 
protein response) that is a cellular stress response related to the “ER 
(endoplasmatic reticulum) stress; this process is usually activated in response to 
an accumulation of unfolded or misfolded proteins in the lumen of the 
endoplasmatic reticulum. If it doesn’t restore the normal function of the cell,  
the UPR process can lead to apoptosis (Lockshin and Zakeri, 2004). The 
“Apoptosis” process was described for the first time by Kerr et al., in 1972, who 
asserted that apoptosis is a mechanism of controlled cell deletion, which appears 
to play a complementary but opposite role to mitosis in the regulation of animal 
cell populations. Its morphological features suggest that it is an active, 
inherently programmed phenomenon, and it has been shown that it can be 
initiated or inhibited by a variety of environmental stimuli, both physiological 
and pathological (Kerry et al., 1972). In particular, they described the 
morphological changes that take place during the evolution of apoptosis. The 
latter characteristically affects disseminated single cells, and is manifested 
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histologically by the formation of small, roughly spherical or ovoid cytoplasmic 
fragments. Electron microscopy shows that the structural changes in apoptosis 
take place in two discrete stages (Fig. 10) (Kerr et al., 1972): the first comprises 
the formation of apoptotic bodies, the second their phagocytosis and 
degradation by other cells. The condensation is presumably a consequence of 
the extrusion of water, but its mechanism is still unknown. The formation of 
apoptotic bodies involves marked condensation of both nucleus and cytoplasm, 
nuclear fragmentation, and separation of protuberances that form on the cell 
surface (Fig. 10) (Kerr, 1971) to produce many membrane compact, but 
otherwise well preserved cell remnants of greatly varying size. The initial 
morphological events have not been identified: apoptotic cells have already 
condensed and separated from their neighbours, and the nuclear chromatin is 
aggregated in dense masses beneath the nuclear envelope (Kerr, 1971). Fully 
developed apoptotic bodies show closely packed organelles, which may 
themselves be condensed, but which are apparently intact, both chemically 
(Kerr, 1965, 1967; Ballard and Holt, 1968) and structurally. Lucent cytoplasmic 
vacuoles and dense masses of nuclear material are seen in some bodies. 
The content of an apoptotic body depends on the cellular constituents that 
happened to be present in the cytoplasmic protuberance that gave rise to it; 
small bodies thus occasionally consist almost entirely of condensed nuclear 
chromatin , whereas others are composed only of cytoplasmic elements. It is 
difficult to determine precisely the time taken for the sequence of events 
described above, even when augmented by various stimuli, the process appears 
to start in individual cells of the same organ or tissue at different times. 
However, examination of the serial changes that take place in several 
experimental models (Kerr, 1971; Crawford et al., 1972; Wyllie et al., 1972b) 
suggests that the process is completed fairly rapidly: bodies may form and 




Fig.10 Morphological features of apoptosis. (Kerr et al. 1972). 
Currently, the morphology and behaviour of apoptotic cells is largely explained 
by activation of caspases (cysteinyl aspartate specific proteinase), and apoptosis 
is considered to be nearly synonymous with caspases activation.  Among them, 
caspase-3 is a frequently activated death protease, catalyzing the specific 
cleavage of many key cellular proteins. However, the specific requirements of 
this (or any other) caspase in apoptosis have remained largely unknown until 
now. Pathways to caspase-3 activation have been identified that are either 
dependent on or independent of mitochondrial cytochrome c release and 
caspase-9 function. Caspase-3 is required for some typical hallmarks of 
apoptosis, and is indispensable for apoptotic chromatin condensation and DNA 
fragmentation in all cell types examined. Thus, caspase-3 is essential for certain 
processes associated with the dismantling of the cell and the formation of 
apoptotic bodies, but it may also function before or at the stage when there is 
the loss of cell viability (Alan et al., 1998).In most cells the machinery for 
killing the cell is present but inactive long before the cell is induced to die, and 
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death appears to be a release from inhibition. So, it is assumed that classical 
apoptosis is a caspase-dependent form of cell death, whether triggered by 
extrinsic (cell surface receptor) or intrinsic (mitochondrial depolarization) 
means. So, the  vast majority of maturing or mature cells possess the machinery 
for self-destruction in the form of inactive proenzymes (pro-caspases) as well as 
machinery for regulating or adjusting the level at which the proenzymes can be 
activated. Cells normally hold the machinery in abeyance, and default to its 
activation when any of numerous conditions define an imperfect situation for 
the cells. Finally, we can say that as an antagonist of cellular proliferation, 
apoptosis contributes to maintaining homeostasis between cell production and 
elimination of superfluous cells produced, that elude mechanisms of control of 
cell development or that undergo genetic damage. 
About autophagy process, this is usually defined as a non-selective vacuolar 
degradative pathway conserved in eukaryotic cells, starting with the formation 
in the cytoplasm of a multi-membrane-bound compartment named 
autophagosome. The discovery of autophagy was contemporary to that of 
lysosomes by de Duve and Wattiaux (de Duve & Wattiaux, 1966). At the same 
time, the term autophagic cell death or type II programmed cell death (PCD II) 
was introduced to describe a cell death different from apoptosis or type I 
programmed cell death (PCD I) (Schweichel & Merker, 1973) and reviewed  by 
Clarke (1990). From these data it appeared that autophagy is a cell response to 
stress, which under certain circumstances can lead to cell death. However, the 
precise role of autophagy as a cell-death mechanism remains to be explored 
(Lipinski, & Degterev, 2003). Autophagy is an evolutionarily conserved 
lysosomal pathway involved in the turnover of long-lived proteins and 
organelles (Dunn, 1994; Klionsky & Ohsumi, 1999; Seglen & Bohley, 1992). 
Autophagy starts with the formation of a multilayer-membrane bound vacuole 
(autophagosoma), in this step, cytoplasmic constituents, including organelles, 
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are sequestered by a unique membrane called the phagophore or isolation 
membrane, which is a very flat organelle like a Golgi cisterna. Complete 
sequestration by the elongating phagophore results in formation of the 
autophagosome, which is typically a double-membraned organelle. This step is 
a simple sequestration, and no degradation occurs. The autophagosomal 
membrane is derived from a pre-autophagosomal structure of uncertain origin 
(Mizushima et al., 2001; Suzuki et al., 2001). A first step towards the formation 
of the autophagosome is the expansion of the pre-autophagosomal membrane. 
This step is dependent upon signaling molecules that modulate the activity and 
the expression of some “autophagy genes”. In the next step, autophagosomes 
fuse with lysosomes (in metazoan cells) or vacuoles (in yeast and plant cells). 
The inner membrane of the autophagosome and the cytoplasm-derived materials 
contained in the autophagosome are then degraded by lysosomal/vacuolar 
hydrolases. These degrading structures are often called “autolysosomes” or 
“autophagolysosomes”. In mammalian cells, most autophagosomes receive 
input from endocytic compartments (Stromhaug & Seglen, 1993; Liou, Geuze, 
Geelen, & Slot, 1997) to form a hybrid organelle called the amphisome 
(Stromhaug & Seglen, 1993). Studies in rat hepatocytes showed that all 
lysosomes are able to fuse with autophagic vacuoles to degrade the sequestered 
material (Fengsrud et al., 1995). In some cases direct fusion of autophagosomes 
with lysosomes was observed (Lawrence & Brown, 1992). However, once 
macromolecules have been degraded in the lysosome/vacuole, monomeric units 
(e.g., amino acids) are exported to the cytosol for reuse; for example, amino 
acids can be used as an energy source through the tricarboxylic acid (TCA) 
cycle, or they can be used to synthetize proteins, which are important for 
adaptation to starvation environments; however, little is known about this step. 
So about roles of autophagy , it is constitutive in all cell types containing a 
lysosomal compartment. This function is involved in cytoplasmic homeostasis 
because it controls the turnover of long-lived proteins and probably also the 
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remodeling of the cytoplasm. But autophagy can be also stimulated in response 
to different situations of stress, such as starvation, change in cell volume, 
oxidative stress, accumulation of misfolded protein, hormonal signaling, 
irradiation and xenobiotic treatment. About  role of autophagy in adaptation to 
starvation, it was seen that the breakdown of proteins by autophagy produces 
amino acids and other elements needed for intermediary metabolism and for 
biosynthetic pathways. For this, it’s clear that amino acids are regulators of 
autophagy. Although autophagy is considered to be a non-selective process, 
selective sequestration of organelles can be observed in various 
pathophysiological and/or stress situations. Definitively, in addition to diseases 
as  myopathies, neurodegenerative disorders and cancer, where alterations in the 
autophagic pathway and/or deficiency in autophagy genes are involved, the role 
of autophagy during physiological processes falls into three categories: (1) 
autophagy is involved in remodeling during development and differentiation; 
(2) autophagy is involved in the production of amino acids when nutrients fall 
short; (3) autophagy is involved in the elimination of unwanted and damaged 
organelles and molecules, which is likely to be an important function during the 
adult life span.  
Free fatty acids (FFAs) are taken up by hepatocytes and converted into 
triglycerides (TGs) for storage with cholesterol in lipid droplets (LDs). LD-
sequestered TGs continually undergo hydrolysis, generating FFAs that are 
predominantly re-esterified back into TGs for storage. Nutrient deprivation 
upregulates TG hydrolysis to supply FFAs for oxidation to meet cellular energy 
demands. An alternative energy source in times of nutrient scarcity is provided 
by the breakdown of cellular components by autophagy. In 2009,  this new role 
of autophagy was discovered by a group of researchers (Singh, et al., 2009); 
they saw that lipid droplets and autophagic components associated during 
nutrient deprivation, and inhibition of autophagy in cultured hepatocytes and 
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mouse liver increased triglyceride storage in lipid droplets. So, the regulatory 
and functional similarities between autophagy and lipolysis, along with the 
capability of lysosomes to degrade lipids, indicated that autophagy may 
contribute to LD and TG breakdown.  
1.4 The phytochemicals  
Phytochemicals are a large group of plant-derived compounds that are 
commonly found in fruits, vegetables, beans, cereals and plant-based beverages 
such as tea and wine (Arts & Hollman, 2005). Based on their chemical 
structure, phytochemicals can principally be categorized into alkaloids, 
flavonoids, pigments, phenolics, terpenoids, steroids and essential oils. 
1.4.1 Flavonoids 
Flavonoids are diphenylpropanes that constitute one of the most characteristic 
classes of secondary metabolites in plants (Cao et al., 1997). It has been shown  
that flavonoids are potent antioxidants, capable of removing hydroxyl radicals, 
superoxide anions and lipid peroxy radicals, and have been reported as having 
antibacterial, anti-inflammatory, antiallergic, antimutagenic, antiviral, 
antineoplastic, anti-thrombotic and vasodilatory actions (Yao et al., 2004; 
Chakraborty & Hancz, 2011). The structural components common to these 
molecules include two benzene rings on either side of a 3-carbon ring, and 
multiple combinations of hydroxyl groups, sugars, oxygens and methyl groups 
attached to these structures create the various classes of flavonoids: flavanols, 
flavanones, flavones, flavan-3-ols (catechins), anthocyanins and isoflavones.  
The use of medicinal plants as fertility enhancers and sex reversal agents in fish 
has been receiving some attention. Moreover, as the components of fish diet 
and/or compounds present in the aquatic environment, phytochemicals may 
induce biological responses in fish including estrogenic effects and delayed 
reproduction, and for this are considered as endocrine disrupting chemicals 
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(EDCs) (Ng et al., 2006; Cheshenko et al., 2008). Among Phytochemicals, 
flavonoids are an important group of endocrine disrupting chemicals. Among 
them there are genistein and dadzein (isoflavones), often called phytoestrogens, 
because of their structural resemblance with 17b-oestradiol and estrogenic 
and/or anti-estrogenic properties. In particular, there are numerous reports of 
genistein exerting estrogenic effects in fish. For example, Bennetau-Pelissero et 
al. (2001) reported increased plasma vitellogenin concentrations in male and 
female fish  fed diets containing either 500 or 1000 ppm genistein until 
spawning. Male fish fed a diet with 500 ppm genistein showed a slight decrease 
in plasma levels of FSH and LH at the end of spermatogenesis, testicular 
development was accelerated, and sperm motility and concentration were 
decreased in a dose-dependent way at spawning. Female fed a diet containing 
50ppm of genistein showed  decreased FSH and LH levels, delayed spawning 
and impaired gamete quality. Contrarily, in yellow perch, Perca flavescens,  
Koet al. (1999) reported that genistein (0.75 and 7.5 mg g 1 diet)  haven’t  
apparent estrogenic effects on reproductive function. This happens because of 
dual role of genistein as not only acts as an estrogenic agonist, but also as an 
antagonist blocking estrogen’s action. About mechanism of action of 
phytoestrogens as endocrine disruptors, it has been seen that phytoestrogens, 
including isoflavones such as genistein and daidzein, bind weakly to estrogen 
receptors so that they can produce or inhibit estrogenic effects.   
1.5 Genistein: sources, structure and metabolism  
Epidemiological data strongly suggested that consumption of plant-based foods 
rich in isoflavones provides beneficial effects for human health (Ososki and 
Kennelly, 2003). Thus, much attention has been given to investigating the 
effects of these compounds, especially genistein, in human physiological and 
pathological states. Soybean is the main source of isoflavones in the human diet, 
it contains between 0.6 and 3.8 g isoflavones/kg fresh weight (Cassidy et al., 
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2000).  The three principal isoflavones found in soy are genistein, daidzein and 
glycetein, generally in a concentration ratio of 1:1:0.2 (Manach et al., 2004).  
 
Fig.11 Chemical structure of genistein, genistin, daidzein and 17b estradiol and are 
presentation of genistein metabolism. (Behloul et al., 2013). 
The particular similitude of isoflavones to 17β-estradiol, enables them to bind to 
estrogen receptors and thus can at least partly explain their effects. After 
ingestion, genistein is released from the glucoside genistin by acid hydrolysis in 
the stomach or by microflora hydrolysis in the intestine. The resulting aglycone 
can either be absorbed or further metabolized to specific metabolites 
(Dihydrogenistein,5-hydroxy-equol) (Matthies et al., 2012). Genistein (4,5,7-
trihydroxyisoflavone) was originally isolated by Perkin and Newbury in 1899 
from Dyer’s Broom (Genista tinctoria) (Perkin and Newbury,1899).This 
naturally derived compound is a member of the isoflavone group of the 
flavonoid family of small molecules, which includes over 5,000 compounds 
(Andersen and Markham, 2006; Veitch and Grayer, 2008). The isoflavones are 
structurally characterized by their 3-phenylchromen-4- one core, that is formed 
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by two benzene rings linked by a heterocyclic pyran ring. In addition to this 
heterocyclic core, genistein and  other members of isoflavone family are 
polyphenols, because of they contain several hydroxyl groups attached to core 
phenyl rings. These phenols confer an antioxidant activity to this class of 
compounds which possess a significant activity against free radicals in tissue 
(Andersen and Markham, 2006). As previously mentioned, genistein’s 
structural characteristics are similar to those of 17β-estradiol; in particular, 
shares both a near identical molecular weight as well as a similar hydroxylation 
pattern, with two key phenolic groups at C7 and C4′ (Fig.12) (Dixon and  
Ferreira, 2002). Importantly, the C7 hydroxyl group is needed for genistein to 
bind to the estrogen receptor (ER). Furthermore, the distance (∼11.5 Å) 
between the C7 and C4′ phenolic groups (highlighted in green, see Fig. 12, 
below) allows for optimal binding of genistein to the ER, as they are in very 
similar positions to the key hydroxyl groups on the estradiol core (Andersen and 
Markham, 2006). It has been shown that both the C4′ and C7 phenolic group 
form key contacts with ERβ, with the C4′ phenol binding to Glu305 and Arg306 
and the C7 phenol to His475 (Pike et al., 1999). Because of these structural 
characteristics, genistein can bind to both α and β isoforms of the ER (Kuiper et 
al., 1998; Mueller et al., 2004), although it binds to ERβ with 20-fold higher 
affinity than ERα  (Kuiper et al., 1997). 
 
Fig.12 Structures of genistein (left) and 17-β-estradiol (right). Genistein’s structure is 
characterized by a 3-phenylchromen-4-one core (highlighted in red) and phenolic 
substitution at the C4′, C5, and C7 positions. The C4′ and C7 phenols of genistein are in 
very similar positions to key hydroxyl groups on estradiol (highlighted in 
green),allowing genistein to bind to the ER. (Pavese et al., 2010). 
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1.6 Genistein: a compound with pleiotropic effects 
Genistein, a soy derived isoflavone, has been reported as a potential therapeutic 
agent with anti-cancer, anti-osteoporosis, anti-oxidant and anti-inflammatory 
effects. Regarding cancer, genistein has been shown to induce apoptosis and 
differentiation in cancer cells, inhibit cell proliferation, modulate cell cycling, 
exert anti-oxidant effects, inhibit angiogenesis and suppress osteoclast and 
lymphocyte functions; these make genistein a promising agent  into treatment of 
cancer. In relation to osteoporosis, it has been seen that genistein exerts a 
significant estrogenic activity and may be an efficient agent in retaining bone  
 
mass. Studies with ovariectomized rats (lacking in endogenous estrogens) have 
demonstrate that genistein is active like estrogens in maintaining bone health 
(Anderson et al., 1998). In tissue cultures in vitro genistein, like estradiol, exerts 
a significant protective activity against experimentally induced bone resorption 
(Yamaguchi et al., 1998) ,and moreover, it stimulates osteoblast-mediated bone 
formation. It has been proved that genistein, not only as agonist of estradiol acts 
on bone health, but also blocking osteoclastic function in vitro through tyrosine 
kinase mechanism. Genistein has been proposed as a promising compound for 
Fig. 13 Pleitropic effects of 
genistein.Genistein(G) inhibits 
preadipocytes   
differentiation,lipidaccumulationandgl
ucose(Glu)uptake in mature 
adipocyte.It enhances lipolysis and 
adipocyte apoptosis and reduces the 
secretion of pro-inflammatory 
cytokines and leptin.It also enhances 
glucose-stimulated insulin secretion, 
reduces reactive oxygenspecies-induced 
b cell damage and ameliorates the 
insulin resistance state by counteracting 
reactive oxygen species,pro-
inflammatory cytokines and leptin 
actions. ROS: reactiv eoxygen species; 
TG: triglyceride; FFA: free fatty acids. 
(Behloul et al., 2013). 
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the treatment of metabolic disorders and for ameliorating diabetes and obesity 
states (Fig. 13). 
The pleiotropic effects of genistein are due to its multiple mechanisms of action 
and involvement of several cellular signaling pathways as estrogen-like activity, 
tyrosine kinase inhibitory effect and 5’ AMP- activated protein kinase (AMPK) 
pathway. Studies conducted on obese diabetic mice and non- obese diabetic 
mice (Choi et al., 2008) have shown that genistein ameliorated glucose and lipid 
metabolism, elevated insulin levels and preserved pancreatic β-cells. Moreover, 
at physiologically achievable concentrations, genistein potentiated glucose-
stimulated insulin secretion in both insulin-secreting cell lines and mouse 
pancreatic islets (Liu et al., 2006). Genistein also protected pancreatic β-cells 
against cytokine-induced toxicity through inhibition of iNOS (inducible nitric 
oxide synthase) gene expression, nitric oxide production, and also, the 
suppression of Erk-1/2 and JAK/signal transducer and activator of transcription 
(STAT) pathways (Kim et al., 2007). Recently, it has been seen that genistein 
protects human pancreas cells, that express estrogen receptor β, against high 
glucose-induced cell apoptosis and the inhibition of their proliferation, through 
estrogen receptor and Bcl-2 pathways (Zhong et al., 2011). 
It has been repeatedly highlighted the bond between oxidative stress and 
metabolic disorders as diabetes, obesity and cardiovascular diseases (Fatehi-
Hassanabad et al., 2010; Grattagliano et al., 2008; Rains and Jain, 2011; 
Schonfeld and Wojtczak, 2008). Chronic exposure to reactive oxygen species 
(ROS) activates stress pathways that affect negatively insulin signaling and are 
involved into insulin resistance, impaired glucose intolerance, β-cell and 
mitochondrial dysfunctions and finally into diabetes state. The main cellular 
producers of ROS are mitochondria and plasma membrane. Free fatty acids 
levels, which are elevated during obesity and diabetes, have been shown to 
influence the production of ROS by a partial inhibition of complexes 1 and 3 of 
 
50 
the respiratory chain into mitochondria and my modulating the reduced NADPH 
(nicotinamide adenine dinucleotide phosphate) activity in plasma membrane. 
Regarding the anti-oxidant activity of genistein, it has been emphasize genistein 
as a compound capable of counteract ROS detrimental effects. Following 
which, its effect on activation of the transcription factors – Nrf1 and Nrf2, 
which have been implicated in the regulation of genes involved in response to 
oxidative stress, was investigated (Hernandez-Montes et al., 2006). These 
transcription factors are involved in the regulation of c-GCS and other 
detoxification proteins. Genistein was found to induce the cytosolic 
accumulation and nuclear translocation of Nrf1 and Nrf2. Ultimately, genistein 
is an antioxidant thanks to its inhibition of the activation of NF-kB stimulated 
by oxidant stress (Davis et al., 2001). 
Beside the oxidative stress, metabolic disorders are also linked to inflammation 
(Garcia et al., 2010), and genistein seems to ameliorate this inflammatory state. 
For example, it reduce the expression levels of TNFα and pro-inflammatory 
citokines in cerebral endothelial cells (Lu et al., 2009), decreases the plasma 
levels of TNFα and interleukin 6 (IL6) in fructose-fed rats (Palanisamy et al., 
2011), and also inhibits the inflammatory process and the progression of non-
alcoholic steatohepatitis induced by high fat diet in rats by decreasing TNFα 
and IL6 levels in serum and liver, by activation of JNK and inhibition of NFkB 
p65 nuclear translocation and IkBα phosphorylation.  
1.6.1 Effects of genistein on adipocytes  
Many studies have reported that genistein has an anti-obesogenic effect in 
ovariectomized mice; in particular, it seems that genistein decreases food intake, 
body weight, fat pad weight and increases apoptosis of adipose tissue (Kim et 
al., 2006; Naaz et al., 2003). Many researchers supposed that these effects of 
genistein may be due to decreased leptin secretion which is the most important 
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adipose derived hormone, implicated in the regulation of energy homeostasis, 
obesity, reproduction, bone formation, wound healing and immunity among 
other biological functions (Peelman et al., 2006). Leptin in mammals is 
produced and secreted primarily by mature white adipocytes (Matson et al., 
1996; Zhang et al.,1994); when fat mass decreases, circulating leptin is reduced, 
leading to stimulated appetite and suppressed energy expenditure (Ahima et al., 
1996; Coppari and Bjørbæk, 2012). In salmonids as in other teleost species 
studied, the liver appears to be the main production site of leptin, as evidenced 
by high hepatic Lep gene expression (Gong et al., 2013; Gorissen et al., 2009; 
Huising et al., 2006; Kling et al., 2012; Kurokawa et al., 2005; Kurokawa and 
Murashita, 2009; Murashita et al., 2008; Pfundt et al., 2009; Rønnestad et al., 
2010), even if leptin has been immunohistochemically detected in primary 
cultured mature adipocytes of Atlantic salmon (Vegusdal et al., 2003) and in 
rainbow trout adipose tissue (Pfundt et al., 2009) using mammalian antibodies. 
So, it is clear the role of leptin as a satiety signal, not only in mammalian, but 
also in teleost species as rainbow trout (Oncorhynchus mykiss), goldfish 
(Carassius auratus), Atlantic salmon. Many of the leptin effects are linked to its 
actions in the central nervous system, in particular, in the basomedial 
hypothalamus where leptin receptor β mRNA is highly expressed (Schwartz et 
al., 2000).  
Nowadays, the idea of the leptin resistance state is associated with common 
forms of human obesity, and, two hypothesis have been proposed to explain it: 
the failure of circulating leptin to reach its targets into brain and/or the 
inhibition of the intracellular leptin receptor β; in this case, two inhibitory 
molecules have been identified: SOCS3 (suppressor of cytokine signaling 3), 
and, PTP1B (protein tyrosine phosphatase) (Munzberg et al., 2005). It has been 
demonstrated that genistein disrupts leptin synthesis in 3T3-L1 preadipocytes 
(Phrakonkham et al., 2008), inhibits its secretion not via estrogen receptor in 
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murine adipocytes (Niwa et al., 2010), but it has been supposed that genistein 
might reduce this leptin resistance also by ameliorating the inflammatory state 
of obesity. Especially, this amelioration could restore the normal leptin influx to 
its targets in brain and/or down regulate the expression of molecules (SOCS3, 
PTP1B), that inhibit leptin receptor β signaling. So, genistein could contribute 
to the recovery of a negative feedback that would decrease the synthesis and the 
secretion of leptin.  
Nowadays, is well known that the process of adipogenesis is controlled by a 
myriad of adipocyte-specific genes expressions such as expression of 
peroxisome proliferator-activated receptor ɤ (PPARɤ), CCAAT/enhancer 
binding protein(C/EBP a) and adipocyte determination and differentiation-
dependent factor1/sterol regulatory element binding protein1c 
(ADD1/SREBP1c). Genistein alone or in combination with other compounds 
suppresses differentiation, adipogenesis and lipid accumulation and increases 
lipolysis (Harmon and Harp, 2001) in 3T3-L1adipocytes. Regarding the 























it has been reported that genistein inhibits adipogenic differentiation of human 
adipose tissue-derived mesenchymal stem cell via Wingless and Int/β catenin 
(Wnt/β-catenin) signaling pathway, such as Extracellular signal-regulated 
kinase/c-Jun-N-terminal kinase (Erk/JNK) signaling, in an estrogen-receptor-
dependent way (Kim et al., 2010). Genistein also inhibits lipid accumulation in 
a dose-dependent manner, via down-regulation of adipocyte specific 
transcription factors as PPARɤ, C/EBPα and glycerol-3-phosphate 
dehydrogenase (Park et al., 2009). Previously, it has been shown that genistein 
also inhibits adipocyte differentiation via activation of 5’ AMP- activated 
protein kinase (Hwang et al., 2005), and promotes expression of C/EBP 
homologous protein that blocks the DNA binding and the transcriptional 
activity of C/EBPβ during differentiation (Harmon et al., 2002).  
Fig.14 Simplified schema of genistein effects on adipocytes and the different suggested mechanisms. 
Erk/JNK: extracellular signal-regulated kinase/c-Jun N-terminal kinase; Wnt/b-catenin: wingless and 
Int/ b-catenin pathway;AMPK:50 AMP-activated protein kinase; C/EBPb: CCAAT/Enhancer binding 
protein b; C/EBPhp: CCAAT/Enhancer binding protein homologous  protein; C/EBPa: 
CCAAT/Enhancer binding protein a; PPARɤ : peroxisome proliferator activated receptor ɤ; 
GPD:glycerol-3-phosphate dehydrogenase ;PARP: poly(ADP-ribose)polymerase; Bax:Bcl-2-associated 
X protein; PKA: protein kinase A; GLUT4:glucose transporter4;(+):activation;(-):inhibition; :   




It has been reported that genistein, because of its tyrosine kinase inhibition 
activity, inhibits glucose uptake in MC3T3-G2/PA6 adipocytes and directly, 
through the glucose transporter 4 (GLUT4), counteracts glucose uptake in 3T3-
L1 adipose cell (Bazuine et al., 2005; Nomura et al., 2008). Recently, it has 
been seen that genistein also inhibits insulin-stimulated glucose uptake and 
reduce ATP in adipocytes and the mechanism proposed seems to involve a 
mitochondrial dysfunction (Szkudelska et al., 2011). Moreover, genistein 
counteracts the anti-lipolytic  action of insulin (Abler et al., 1992), and also, 
inhibits, in an estrogen receptor-independent manner, the inhibitory action of 
insulin on epinephrine-induced lipolysis in isolated rat adipocytes; this action 
seems to be due to protein kinase A (PKA) activation and elevation of cAMP 
levels (Szkudelska et al., 2008). Genistein has been shown to induce cell 
apoptosis via mitochondrial damage; although on adipocytes, low doses of 
genistein increase cell viability, while high doses decrease it (Park et al., 2009). 
In vivo and in vitro studies have shown that genistein has anti-obesogenic 
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Because of plasma concentrations of genistein, after a regular consumption of it,  
are much lower than those in vitro, combinations with other compounds were 
investigated (Tab.4). 
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Tab.4 Synergistic combinations of genistein with other compounds. (Behloul et al. 2013) 
For example, genistein with guggulsterone induces apoptosis and suppression of 
differentiation and adipogenesis in 3T3-L1 adipocytes, through an increase in 
production of active caspase 3, and an induction of the expression of pro-
apoptotic Bcl-2-associated x protein (Bax) and the release of cytochrome c. 
Genistein with vitamin D combined promote the inhibition of lipid 
accumulation and the induction of apoptosis in 3T3-L1 adipocytes, through a 
suppression of PPARɤ, C/EBPα, and an induction of vitamin D receptor 
expression (Rayalam et al., 2008).  
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2. Aims of research 
The management of fat deposition has become a key area of interest in fish 
farming in the quest to obtain a high-quality product with good nutritional value 
and to maintain fish health. The administration of high-lipid feed usually can 
lead to an unwanted increase in fat deposition that alters sensory and 
organoleptic characteristics (Kjær et al., 2008; Turchini et al., 2009). On one 
hand the potential anti-obesogenic effect of genistein in rainbow trout can be 
positive as ingredient in fish diets, on the other, it isn’t (i.e adipocytes 
apoptosis). So, the hypothesis of work is that genistein can have in vivo and in 
vitro anti-adipogenic and anti-obesogenic effects, as shown previously in 
mammals. Moreover, we want to analyze the main pathways through which it 
exercises this role on Oncorhynchus mykiss lipid metabolism. Following, are 
reported the purposes of the research in detail: 
1. To determine the effect of an intraperitoneal injection of genistein on 
lipid metabolism related genes expression; to evaluate the effect of 
genistein on apoptosis-related genes expression, and on autophagy-
related genes expression. All of this, in adipose tissue, liver and white 
muscle of rainbow trout. 
2. To describe the potential anti-obesogenic effect of genistein, in 
particular, analyzing the effects of genistein on viability and 
differentiation in rainbow trout adipocytes in primary culture. 
 






3. Materials and methods 
 3.1 Animals  
Juvenile (in vivo experiment) and adult (in vitro experiment) rainbow trout, 
approximatively 80g and 250g in weight respectively, were obtained from 





with a temperature controlled freshwater recirculation system (18±1°C), and 
12L:12D photoperiod in the facilities of the Faculty of Biology at the University 
of Barcelona. Fish were fed with a commercial diet (Skretting, Burgos, Spain) 
twice daily. Juvenile animals were fasted 2 hours before the injection to 24 
hours post-injection; adult animals for in vitro experiment were fasted 24 hours.  
 
3.2 Experimental design in vivo: intraperitoneal injection 
After 15 days of acclimation, juvenile rainbow trout were anesthetized (MS-
222, 0.1g/L), and received intraperitoneal injections of 4.64µL volume per g 
body mass containing genistein at different dose (see above). Both for the 
experiment in vivo than that in vitro, genistein, 17β-estradiol (E2), and 
fulvestrant (estrogen receptor antagonist) were initially resuspended in DMSO 
(Dimethyl sulfoxide). Only for in vivo experiments, genistein and E2 were 
diluted then 1:3 in sesame oil. Treatments were :  
1) Control containing DMSO diluted 1:3 in sesame oil; 
2) Genistein at 5µg/g of body mass; 
3) Genistein at 50µg/g of body mass; 
4) 17β-estradiol at 5µg/g of body mass. 
After 24 hours, fish were first anesthetized, and then sacrificed by a blow to  the 
head; blood samples are taken from the caudal aorta, samples of liver, 
perivisceral adipose tissue and white muscle were harvested and stored at -80°C 
until analysis.   
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3.3  Gene expression analysis 
3.3.1 RNA isolation 
All tissue samples were processed individually, both those of adipose tissue that 
those of the liver (N=31), and those of white muscle. To isolate total RNA from 
tissues, approximately 0,1g (adipose tissue), 0,02-0,03g (liver), and 0,1g (white 
muscle) were homogenized in 1mL TRIzol (Ambion, Alcobendas, Spain) 
according to the following protocol: 
Homogenization of tissues for RNA 
Material 
-Falcons 
-Eppendorfs 1.5 mL 





1. Add to every falcon 1mL of “TRIZOL” 
2. Weigh samples; they must be more or less 0.1g 
3. Put them into every falcon with “TRIZOL” 
4. Homogenize samples by a polytron: 2-3 times (30”)  
at 12000 rpm 
5. Samples homogenates  must be put into new eppendorfs 
 
 
Fig. 15 Samples Homogenization 




6. Centrifuge at 4°C for 10 min at 12000 rcf 








The “TRIZOL” must be always into ice; it is a reaction based on water and 
phenol which extracts nucleic acids and protects from degradation of  RNAses. 
 









1. Put 200µL of Chloroform into every eppendorf with homogenate tissue 
and vortex for 20” 
Fig.16 Centrifuge machine. 
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2. Let rest 5 min at room temperature so that the phases begin to separate 
themselves 
3. Centrifuge at 4°C for 15 min at 13000 rcf ; then there will be 3 phases 
well differentiated: a lower with chloroform, an intermediate with protein 
and an higher with RNA plus water 
4. Get only the upper phase and put it into new eppendorfs 
5. Put 500µL of Isopropanol (it helps to precipitate RNA) and mix by 
inversion (4-5 times) 
6. Let rest 10 min at room temperature 
7. Centrifuge at 4°C for 10 min at 13000 rcf , so that there will be an higher 
aqueous phase and a white pellet (it includes RNA)  
8. Reject an aqueous phase and don’t touch pellet 
9. Add 1mL of Ethanol 75% 
10. Centrifuge at 4°C for 5 min at 7500 rcf  
11. Repeat the last three steps, so that we have two washes by Ethanol 75% 
12. Reject aqueous phase and let dry pellet so that Ethanol evaporates 
13. Re-suspend pellet by adding 30µL of RNAse Free water 
14. Quantify RNA into samples by NANODROP 
The quantity of the RNA was determined by measuring the 
absorbance at 260nm and 280nm with a ND-2000 NanoDrop 









3.3.3 Complementary DNA synthesis   
For the reverse transcriptase reaction (RT), 500-1000ng of total RNA were 
treated with DNase Ι (Life Technologies, Alcobendas, Spain) in order to remove 
all genomic DNA, and furthermore the RNA was reverse transcribed with the 
Transcriptor First Strand cDNA synthesis (Roche, Sant Cugat del Valles, 
Spain), according to the following protocol: 
DNase + RT protocol 
- cDNA synthesis (DNase + Denaturalization+ RT) 
DNase treatment kit (vf= 11µL) 
Eppendorfs 200µL RNase-free 
Calculate the amount of DEPC H2O (µL) to use with Excel, based on the 
amount of RNA (µg). 
CNTC= no RNA 
CRTC= no RT enzim. Use RNA from higher concentrated sample 
 
STEPS: 
1. Label the eppendorfs  
2. Prepare mix: DNase (1µL) + Buffer (1µL) (+2-3 pipetting error). Keep on 
ice. 
3. Add the DEPC water corresponding to each sample (see Excel). 
4. Add the amount of RNA from each sample except CNTC (see Excel). 
5. Add MIX (2µL/eppendorfs) and put the timer 15 min from the first 
sample (room temperature). 
6. After 15min, add 1µL of EDTA to stop reaction. 
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Denaturalization kit cDNA (vf= 13µL) 
STEPS: 
1. Label the final eppendorfs with sample code. 
2. Make a MIX with oligdT’s (1µL) + Random hexamer (2µL) (+2-3 
pipetting error). Keep on ice. 
3. Add 10µL from the sample (DNase treatment) to new eppendorfs. 
4. Add MIX (3µL/Eppendorf). 
5. Place eppendorfs into PCR machine and select Denaturalization protocol 
(10min at 65°C). 
 
RT. Retro- transcription kit cDNA (vf= 20µL) 
 
STEPS: 
1. Prepare MIX with Buffer (4µL) + Protector (0.5µL) + dNTPs (2µL) + 
RT enzim (0.5µL) (+2-3 pipetting error). Keep on ice. 
Fig.18 PCR machine Bio-Rad. 
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2. Add MIX (7µL/Eppendorf) to all samples except the CRTC ( add water 
instead of RT enzim). 
3. Place eppendorfs into PCR machine and select RT protocol (~90min). 
 
3.3.4 Real-time quantitative reverse transcription PCR (Real-time 
qRT-PCR) 
A serial dilution in nuclease-free water of cDNA derived from a RNA pool of 
experimental samples (liver, adipose tissue and white muscle) was amplified to 
construct standard curves for both target and reference genes. Standard curves 
were included in each run to determine amplification efficiency (E) and dilution 
at which it has the highest gene 
expression.After then, both cDNA liver 
samples and adipose tissue samples were 
diluted 1:10 and 1:50 in nuclease free-water; 
while white muscle samples were diluted 
1:10, 1:50, 1:100, 1:200 in nuclease free 
water. Real-time qRT-PCR measurements 
were performed by preparing 4µL PCR mix 
(2,5µL of Sybr-Green; 0,25µL of primer 
(F+R), and 1,25 of MQ water) and by applying 1µL of diluted cDNA samples; 
for some genes, 3µL of PCR mix was prepared (2,5µL of Sybr-Green; 0,125µL 
of primer (F+R), and 0,375 of MQ water, or 2,5µL of Sybr-Green, 0,25µL of 
primer (F+R), and 0,25µL of MQ water) with 2µL of diluted cDNA samples. 
The quantitative polymerase chain reaction primer sequences for the genes 
analyzed (EF1α LPL, GAPDH, HSL, FAS, EM, LXR, PPARβ, PPARα, β-actin, 
Ubiquitin, Lep, ER2α, ER2β, VTG, LC3B, SQSTM1, ATG12L, ATG4B, 
Fig.19 Real-time PCR machine Bio-rad. 
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CASP3, CASP8, P53, NUPR1), and the reference genes of adipose tissue, liver 
and white muscle are shown in Tabl. 23. 
Tab.5 Rainbow trout sequences used for qPCR. 
Gene symbol                                                                   T°                                                                                Sequence 5’-3’                                                 
Reference genes for adipose tissue and liver 
Ubiquitin F                                                                       58°                                                   5’- ACAACATCCAGAAAG-3’ 
Ubiquitin R                                                                       -                                                       5’- AGGCGGGCGTAGCACTTG-3’ 
β-actin F                                                                           62°                                                   5’-ATCCTGACAGAGCGCGGTTACAGT-3’ 
β-actin R                                                                           -                                                       5’-TGCCCATCTCCTGCTCAAAGTCCA-3’ 
EF1αF                                                                              59°                                                    5’-TCCTCTTGGTCGTTTCGCTG-3’ 
EF1αR                                                                              -                                                        5’-ACCCGAGGGACATCCTGTG-3’ 
 
Reference genes for white muscle 
Ubiquitin F                                                                       58°                                                   5’- ACAACATCCAGAAAG-3’ 
Ubiquitin R                                                                       -                                                       5’- AGGCGGGCGTAGCACTTG-3’      
EF1αF                                                                               59°                                                   5’-TCCTCTTGGTCGTTTCGCTG-3’ 
EF1αR                                                                               -                                                       5’-ACCCGAGGGACATCCTGTG-3’        
 
Lipid metabolism-related genes 
LPLF                                                                               59°                                                      5’-TAATTGGCTGCAGAAAACAC-3’ 
LPLR                                                                               -                                                          5’-CGTCAGCAAACTCAAAGGT-3’ 
GAPDHF                                                                        62°                                                       5’-GACACCTAGTGGAGGCTGTC-3’ 
GAPDHR                                                                        -                                                           5’-ATGACCTTGCCCACAGCCTT-3’ 
HSLF                                                                              58°                                                       5’-AGGGTCATGGTCATCGTCTC-3’ 
HSLR                                                                              -                                                           5’-CTTGACGGAGGGACAGCTAC-3’ 
FASF                                                                              54°                                                        5’-GAGACCTAGTGGAGGCTGTC-3’ 
FASR                                                                              -                                                            5’-TCTTGTTGATGCTGAGCTGT-3’ 
PPARαF                                                                         54°                                                        5’-CTGGAGCTGGATGACAGTGA-3’ 
PPARαR                                                                         -                                                            5’-GGCAAGTTTTTGCAGCAGAT-3’ 
PPARβF                                                                        59°                                                         5’-CTGGAGCTGGATGACAGTGA-3’ 
PPARβR                                                                         -                                                            5’-GTCAGCCATCTTGTTGAGCA-3’ 
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LEPF                                                                           60°                                                 5’-TTGCTCAAACCATGGTGATTAGCA-3’ 
LEPR                                                                           -                                                     5’-GTCCATGCCCTCGATCAGGTTA-3’ 
LXRF                                                                          62°                                                 5’-TGCAGCCGTATGTGGA-3’ 
LXRR                                                                          -                                                    5’-GCGGCGGGAGCTTCTTGTC-3’ 
ER2αF                                                                        60°                                                 5’-AGACGGTCATCTCGCTGGAAG-3’ 
ER2αR                                                                         -                                                    5’-ACACTTTGTCATGCCCACTTCGTA-3’ 
ER2βF                                                                        60°                                                 5’-AGAGGAAGTGAACTCCTCCTCAGG-3’ 
ER2βR                                                                         -                                                    5’-GATAGTAGCACTGGTTAGTTGCTGGAC-3’ 
VTGF                                                                         58°                                                 5’-GAGCTAAGGTCCGCACAATTG-3’ 
VTGR                                                                         -                                                    5’-GGGAAACAGGGAAAGCTTCAA-3’ 
Autophagy-related genes 
LC3BF                                                                      57°                                                  5’-GAACAGTTTGACCTGCGTGAA-3’ 
LC3BR                                                                       -                                                     5’-TCTCTCAAtGATGACCGGAATCT-3’  
SQSTM1F                                                                57°                                                  5’-AGCCCACTGGGTATCGATGT-3’                              
SQSTM1R                                                                 -                                                     5’-GGTCACGTGAGTCCATTCCT-3’ 
ATG12F                                                                   60°                                                  5’-GATGGAGGCCAATGAACAGC-3’ 
ATG12R                                                                     -                                                    5’-GCGTTTGAACTGAAAAGGGCTAA-3’ 
ATG4BF                                                                   60°                                                 5’-TATGCGCTTCCGAAAGTTGTC-3’ 
ATG4BR                                                                    -                                                    5’-CAGGATCGTTGGGGTTCTGC-3’ 
 
Apoptosis-related genes 
CASP3F                                                                  57°                                                   5’-TTTGGGAGTAGATTGCAGGG-3’ 
CASP3R                                                                   -                                                      5’-TGCACATCCACGATTTGATT-3’ 
CASP8F                                                                  56°                                                   5’-CAGCATAGAGAAGCAAGGGG-3’ 
CASP8R                                                                   -                                                      5’-TGACTGAGGGGAGCTGAGTT-3’ 
P53F                                                                        56°                                                   5’-GTGGAATTTGATCCGAGTCTGT-3’ 
P53R                                                                         -                                                      5’-AGTGTCCAGGGTAGAAATGGAG-3’ 
NUPR1F                                                                 56°                                                   5’-CGAAGAAGCACACTACGATCAA-3’ 
NUPR1R                                                                  -                                                      5’-TCAGTCCGATTTCTCTCTTGGT-3’                            
Abbreviations: EF1α, elongation factor  1α; LPL, lipoprotein lipase; GAPDH, Glyceraldehyde 3-phosphate dehydrogenase                
;HSL, hormone sensitive lipase; FAS, fatty acid synthase; PPAR, peroxisome proliferator-activated receptors; LEP, leptin; LXR, liver X 
receptor; ER, estrogen receptor; VTG, vitellogenin;LC3B ( MAP1LC3B), Microtubule-associated protein 1 light chain 3 beta; SQSTM1, 
sequestome-1; ATG, autophagy- related; CASP, caspase; P53, phosphoprotein 53; NUPR1, nuclear protein; qPCR, quantitative 
polymerase chain reaction. 
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3.4 Experimental design in vitro: cell culture 
To avoid contamination from the gastrointestinal tract, adult fishes were fasted 
24 hours before the experiments. The cell culture was performed according to 




1. Stock Krebs preparation ( x 10) 
It is necessary to prepare 500mL of Krebs the day before beginning the 
culture, and, to aliquot it in equal parts of 50mL, and, to freeze it. These 
amounts are good for cultivation trout. 
Reagents Concentration (mM) X 500 mL  (g) (x10) 
NaCl 117.5 34.33 
KCl 5.6 2.09 
CaCl2 (dehydrated) 2.52 1.85 
MgSO4 1.18 1.45 
NaH2PO4 (monohydrated) 1.28 0.88 
 
Reagents Amounts 
Stock Krebs (x 10) 50mL 
Distilled water (mQ) 445mL 
NaHCO3 (25mM) 1.05g 
D-Glucose (5.5mM) 0.495g 









3. Erythrocyte buffer preparation 
To prepare 100mL of buffer: 





    Notes: Adjust pH at 7.3 and put the solution in the autoclave. 
4. Collagenase 
Preparing collagenase Type II sigma C6885 (130U/mL). Filtering 
collagenase by filter 0.22µm (Millipore CatN° SVGP01050).  
(130 U/mL) * (mg/475U) * mL of Buffer Krebs = Xmg of collagenase into 
XmL of  KBSA 1% 
 475=  units of collagenase that are written on bottle (this value can 
varies)   
 mL of Buffer Krebs= volume of Buffer Krebs to add. It is depends on 
amount of tissue (per gram of tissue extract, it need to add 5mL 
(1g/5mL). 
 
5. Medium of growth (for 500mL) 
 
Reagents Amounts 
FBS (Sigma F7524-500 mL) 50 mL 
Antibiotic (1%) (mix Sigma A5955-
100 mL) 
5 mL 
L-15 (Leibovitz’s Ref. 11415) Add to complete the volume 
 
6. Medium of differentiation (for 50mL) 
 




- Dexametasone (4°C, D2915, Sigma 1mM into water; PM 392.5 g) 12,5 
L 
 
- IBMX (-20°C, 17018, Sigma stock 1M in DMSO; PM 222,25 g) 50 L 
 




7. Gelatine 1% 
 
The bottle (dust) must be preserved  sterile, and, it must be opened into cape. 
It is possible to choose an amount, and, when we go to prepare it outside 
cape (for example: 150mL), we put 1.5g of gelatin plus 150mL of distilled 
water, and then, we put the solution in the autoclave. Finally, this solution 
must be rated.  
 
8. Feral bovine Serum (FBS) 
 





The day before culture 
 
Prepare the plates with gelatine 1% (1mL in every well) into cape, put them 3 
hours into incubator at 18°C, and then, wash with PBS (Phosphate Buffered 
Saline) sterile (500µL/ well) twice, then, put the plates with PBS into incubator 







The day of culture 
 
 Turn on the cap and select UV. 
 Prepare 500mL di Krebs-HEPES solution and mix it with CO2 5%. 
 Weight 0.5g of anesthetic ms222 (Ethyl 3-aminobenzoate 
methanesulfonate). 
 Filter ~ 370mL of Krebs-HEPES solution with help of syringe and filter 
of 0.22µm (Millipore CatN° SVGP01050), the remaining mL aren’t 
filtered and into them put 1.3g of BSA 1% (Albumin from bovine serum), 
then put them into incubator. 
 Put the dissection material  into the cape. 
 Put 4 falcons with 5mL of Krebs-HEPES solution plus 50µ of antibiotic 
and put this solution into ice. 
 
Sacrifice fish 
Anaesthetize two fishes at a time, and then, kill them by a blow to the head. 
After that, weight fishes and extract adipose tissue from them (5g for every 
falcon). 
Digestion and incubation 
 
 Put into the cape a beaker for waste. 
 Prepare the amount of collagenase type II (130U/mL) to put into the 
Krebs-HEPES solution (not filtered) plus 1% BSA. This depends on 
amount of adipose tissue extract. Prepare 5mL of medium/gram of tissue 
extract. For example if we extract 16g of tissue (4g for 4 falcons),we will 





130U x 130mL 
_____________ = 24.3mg of collagenase 
       693.2 
 
 Filter collagenase into the cape with help of syringe and filters (Stevirex 
GP 0.22µm). 
 Put adipose tissue of falcons (one by one) into a petri and, with help of 
two scalpels, cut tissue and put it into a new falcon, adding 5mL of Krebs 
filtered. 
 Remove lower part of falcons and add to every falcon 5mL/g of medium 
filtered with collagenase. 
 Put falcons into the incubator at 18°C for an hour on the roller. 
 Put falcons in ice and filter the content in a new falcon with help of filters 
for falcons (100µm) (Filters falcon Ref. 352360). 
 Complete the volume up to 50ml with Krebs-HEPES and centrifuge at 
1500 rpm for 10 minutes at 4°C. 
 After centrifuging, take only the precipitate (erythrocytes plus pre-
adipocytes), remove the remainder by decantation. 
 Put in every falcon 5ml of erythrocytes buffer for 5-10 minutes at room 
temperature and with help of sterile pipette dilute precipitate in buffer. 
 Join the content of two falcons in a new one, filtering it by filters for 
falcons (100µm) without taking lipids in the upper part. 
 Wash falcon (with remaining lipids) by 5ml of Krebs-HEPES, then, take 
only the Krebs (without lipids) and put it in the new falcon. 
 Add to falcon (with the filtered content) Krebs-HEPES until to arrive at 
35ml. 
 Centrifuge in the same conditions. 
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 Remove the upper part of the centrifuged from falcons, put 1ml of 
medium of growth and re-suspend by a pipette; then, add the remaining 
medium of growth to arrive 2ml. 
 
Cells count 
     Put into eppendorf: 
 
 20µl of pre-adipocytes 
 10µl of medium of growth       
 10µl of trypan blue 
 
Put into  Neubauer chamber culture room 20µl after having put a coverslip. 
After cells count, it needs to do a media, multiply by 2 (factor of dilution), 
multiply by the total volume and multiply by 10000 (factor of plate) to 
obtain total number of cells; while, without total volume to obtain number of 







The day after the culture  
 Take from the fridge L-15 and medium of growth and put them into cap 
for about 30 minutes. 
 Remove medium from the plates with help of pipette. 
 Put 1ml of L-15 in every well (into plates composed of 12 wells) to do 
the washing of plates. 




 Change medium of growth every 2 days. 
 
Differentiation 
When cells are confluent (seventh day of culture), add medium of 
differentiation. 
Treatments were the following:  
1. Control containing 0,1% of DMSO; 
2. Genistein at 10µM; 
3. Genistein at 100µM; 
4. E2 at 1µM; 
5. Genistein (10µM) + Fulvestrant (2µM); 
6. Genistein (100µM) + Fulvestrant (2µM); 
7. E2 (1µM) + Fulvestrant (2µM). 
The initial concentrations of compounds were: 
1. Genistein: 10mM 
2. E2: 100µM 
3. Fulvestrant: 100µM 
 
3.5 Cytotoxicity assay: MTT assay for the cellular viability 
To describe the potential non-viable effect of genistein in rainbow trout 
adipocytes in primary culture, it was performed a colorimetric assay: bromide of 
3-(4,5-dimethylthiazol-2-ilo)-2,5-diphenyltetrazolium (MTT).It is a colorimetric 
assay (use to examine the cellular survival and proliferation, mainly), through 
which we can determine a certain enzyme activity, thanks to a change of colour. 
This assay is based on the metabolic reduction of MTT (a yellow water-soluble 
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salt) to a blue compound (known as formazan); this reaction happens thanks to 
mitochondrial succinate-dehydrogenase enzyme that dissociates the tetrazolium 
ring of MTT molecule. In this way, we can estimate the number of active 
mitochondria, and so, the number of life cells, because the amount of alive cells 
is proportional to the amount of formazan produced. The MTT metabolized to 
formazan forms water-insoluble crystals which are entrapped into cells, so they 
must be solubilized in an organic solvent before carrying out a colorimetry. 
 
Preparation of the stock solution MTT 
Put 5 mg of MTT (ref. M5655 500mg, SIGMA) per millilitre of PBS          
(Phosphate Buffered Saline). Then, wrap it in an aluminum foil, this because of 




Fig.20 MTT salt. 
 
After the preparation of stock solution MTT, treatments were prepared, and on 
the fifth day of culture (beginning of cell proliferation) it was performed 
stimulation of the plates with the following treatments: 
1. Control (GM+ DMSO) 
2. G10µM 
3. G100µM 
4. E2 1µM 
5. E2 (2µM) + Fulvestrant (2µM) 
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6. G (10µM) + Fulvestrant (2µM) 
7. G (100µM) + Fulvestrant (2µM) 




1. Put 50µL of MTT plus 450µL of medium in every well of plate (if it is 
composed of 12 wells), or, 100µL of MTT plus 900µL of medium if it is 
composed of 6 wells.  
2. You leave it in the incubator for 3 hours. When you jab out it from the 
incubator, it is necessary to observe the blue crystals under the 
microscope. 
3. Wash the wells with PBS once (1mL in every well). 
4. Add 150µL (if the plate is composed of 12 wells), or, 250µL (if it is 
composed of 6 wells) of DMSO (Dimethyl sulfoxide) in every well to 
dissolve crystals formed. Then, put the plates into incubator for 2 hours 
(in case of osteoblasts), or, we  examine them immediately (in case of 
adipocytes).  
5. Put 100µL (once, if the plate is composed of 12 wells; twice, if it is 
composed of 6 wells) into a plate ELISA and measure the absorbance at 
570nm and at 650nm by a spectrophotometer (TECAN). The formazan 
solution absorbs light at 570nm, not at 650nm; for this, the final optical 
density (OD), obtained about formazan produced, can be calculate by 
subtraction between two absorbance (570nm-650nm). 
  
“DMSO” is an uncolored organic solvent with the capacity of crossing 
epidermis and cellular membranes, quickly. It is a solvent that in solution 
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doesn’t release protons to form hydrogen bonds and it is highly polar. It is 
miscible both water and organic solvents.  
 
3.6 Cytochemical assay: ORO (Oil red oil) assay 
The lipophilic dye Oil Red O (ORO) is widely used to characterize the fat cells 
differentiated, because it is a fat-soluble dye capable of staining neutral 
triglycerides and lipids, highlighting them in red. 
 
              Fig.21 Rainbow trout mature adipocytes highlighted in red with the dye ORO. 
 
In the present work, to investigate the potential anti-differentiation effect of 
genistein in rainbow trout adipocytes in primary culture, the seventh day of the 
cell culture, stimulation of the plates was performed with the following 
treatments: 
1. Control (DM + DMSO) 
2. G10µM 
3. G100µM 
4. E2 1µM 
5. E2 (2µM) + Fulvestrant (2µM) 
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6. G (10µM) + Fulvestrant (2µM) 
7. G (100µM) + Fulvestrant (2µM) 
After preparing the Working solution ORO (in 36% TEP): 
Stock solution ORO: 500mg ORO/ 100ml 60% TEP (Triethyl phosphate) 
 
                                12ml stock solution ORO + 8ml H2O 
                                                                Filter with paper Whatmann (n°4) 
                             Working solution ORO (in 36%TEP) 
3 days after (72h), it was done the dye of triglycerides with ORO, according to 
this protocol: 
 Wash cells with PBS. 
 Fix them for an hour with formalin 10% (or formaldehyde 3,7%). 
 Do three washes with distilled water (1ml in every well into plates 
composed of 12 wells). 
 Dye with Working solution ORO (1ml in every well into plates composed 
of 12 wells) for 2 hours. 
 Do three washes with distilled water.  
 
Extraction of triglycerides  
 Let dry cells. 
 Add isopropanol: 250µL into plates composed of 6 wells (or 150µL for 
plates composed of 12 wells) for 30 minutes. 
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 Put 100µL x2 (for plates composed of 6 wells), or 100µL (for plates 
composed of 12 wells) into wells of ELISA plate and analyze at 490nm 
with TECAN. 
 
Dye and extraction of proteins  
 2 washes with distilled water 
 Add 1ml of Comassie solution for an hour at room temperature. 
 Washes with distilled water twice. 
 Add propyl glycol: 1ml (for plates composed of 6 wells) or 500µL (for 
plates composed of 12 wells) for an hour at 60°C. 
 Put 100µl x2 (for plates composed of 6 wells) or 100µL (for plates 
composed of 12 wells) into wells of ELISA plate and analyze at 630nm 
with TECAN. 
 
Count TG/proteins: divide the reading at 490nm for reading at 630nm. 
 
3.7 Statistical analysis 
All data were analyzed using the statistical software IBM SPSS statistics 19. 
Data are presented as means values ± SEM (standard error of the mean). For in 
vitro experiments, n=4 independent experiments from 4 different cell isolations 
were used. For in vivo experiments, n=9 fish were analyzed. Statistical 
differences were analyzed in log-transformed data. To verify data normality, it 
was done Shapiro-Wilk test; to verify the homogeneity of variances, Levene test 
was done. The results were analyzed by 1-way ANOVA followed by Tukey test 
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(Levene test not significant) or Dunnett test (Levene test significant). When the 
data did not follow the ANOVA presumptions, the non-parametric Kruskal-
Wallis followed by Mann-Whitney tests were performed. Differences were 
considered significant at P<0.05. 
 
4. Results  
4.1 In vivo results: Gene expression analysis in adipose tissue and liver 
Expression of estrogen receptors, and lipid metabolism-related genes after 
genistein or 17β-estradiol administration, in adipose tissue and liver, are 
presented in fig.22. Expression of VTG was also determined in liver to confirm 
the effectiveness of the injected compounds. 
In adipose tissue, high concentration of genistein (50µg/g) increased FAS, 
PPARβ, GAPDH and LXR expression. Regarding LPL, HSL and LEP, no 
significant effect was seen. 
In liver, instead, genistein at 50µg/g increased HSL, and GAPDH expression, 
but no significant effect in the other genes was observed.  
In adipose tissue, E2 induced a tendency to increase FAS, PPARβ, GAPDH and 
LXR expression, but it isn’t a significant effect; 
In liver, E2 slightly increased FAS and HSL expression, but not significantly; 
while, E2 increased PPARα and GAPDH expression strongly.  
Regarding VTG in liver, both E2 and the high dose of genistein (50µg/g) 
increased its expression significantly.  
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Regarding estrogen receptors ER2α and ER2β, the high dose of genistein 
(50µg/g) decreased ER2α both in adipose tissue and liver, while in liver it 
decreased ER2β.  
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Fig.22 Effects of E2 and genistein (5µg/g and 50µg/g) on expression of estrogen 
receptors (ERs), vitellogenin (VTG) and lipid metabolism related genes of 
Oncorhynchus mykiss both adipose tissue and liver. Gene expression data are presented 
as relative units using Ubiquitin, EF1α and β-actin as housekeeping genes. Data are 
shown as means ± S.E.M. Treatments bars are relative to the control. Different letters 
indicate significant differences, P< 0,05. FAS, fatty acid synthase; LPL, lipoprotein 
lipase; HSL, hormone sensitive lipase; PPARs, peroxisome proliferator-activated 
receptor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LXR, liver X receptor; 
LEP, leptin; VTG, vitellogenin. 
 
Expression of apoptosis-related genes and autophagy-related genes after 
genistein or 17β-estradiol administration, in adipose tissue and liver, are 
presented in fig. 23. The autophagy-related genes were: CASP3, CASP8, and 
P53; while,  autophagy-related genes were: LC3b, ATG4b, ATG12l.  
In adipose tissue, genistein at 50µg/g decreased CASP3, and increased LC3b 
and ATG4b. 
E2, instead, induced a tendency to decrease CASP3, and to increase ATG4b, but 
these effects weren’t significant statistically. 
In liver, genistein did not have a significant effect on CASP3 and CASP8, only 
the lower dose of genistein (5µg/g) decreased CASP8, significantly. On the 
other hand, the high dose of genistein (50µg/g) increased autophagy-related 




E2, in liver, increased apoptosis-related genes CASP3 and CASP8, appreciably; 
regarding autophagy-related genes, E2 decreased LC3b, and increased ATG12l, 




Fig.23 Effects of E2 and genistein (5µg/g and 50µg/g) on apoptosis-related genes and 
autophagy-related genes of Oncorhynchus mykiss both adipose tissue and liver. Gene 
expression data are presented as relative units using Ubiquitin, EF1α and β-actin as 
housekeeping genes. Data are shown as means ± S.E.M. Treatments bars are relative to 
the control. Different letters indicate significant differences, P< 0,05. CASP3, Caspase 3; 
CASP8, Caspase 8; P53, Tumor protein; LC3b, light chain 3b protein; ATG4b, 




4.2 In vivo results: Gene expression analysis in white muscle 
Expression of estrogen receptors, and lipid metabolism-related genes after 
injection of genistein or 17-β estradiol in white muscle are showed in fig. 24. 
The lower dose of genistein (5µg/g) increased FAS, HSL, PPARα, PPARβ and 
LXR significantly. A significant down-regulation of GAPDH by genistein at 
5µg/g was also seen. Genistein at 50µg/g raised FAS, HSL, PPARα, and LXR, 
with a tendency to increase PPARβ, even if not significantly. GAPDH, instead, 
was not modified. 
E2 increased only PPARβ mRNA levels appreciably, with a tendency to rise the 
other genes (such as FAS, GAPDH and LXR) but not significantly. 
Regarding estrogen receptors ER2α and ER2β, the lower dose of genistein 
(5µg/g) increased both of them significantly; while the high dose of genistein 
(50µg/g) increased ER2β strongly, and tended to up-regulate ER2α mRNA 
levels, but this effect was not significant. 














Fig.24 Effects of E2 and genistein (5µg/g and 50µg/g) on expression of lipid metabolism-
related genes of Oncorhynchus mykiss, and estrogen receptors (ERs) in white muscle. 
Gene expression data are presented as relative units using Ubiquitin and EF1α as 
housekeeping genes. Data are shown as means ± S.E.M. Treatments bars are relative to 
the control. Different letters indicate significant differences, P< 0,05. FAS, fatty acid 
synthase; LPL, lipoprotein lipase; HSL, hormone sensitive lipase; PPARs, peroxisome 
proliferator-activated receptor; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; 
LXR, liver X receptor. 
 
Expression of apoptosis-related genes and autophagy-related genes after 
genistein or E2 administration in trout white muscle are shown in fig. 25.  
The lower dose of genistein rised ATG12l mRNA levels in a significant way, 
but not ATG4b. Regarding apoptosis-related genes, genistein at 5µg/g 
decreased only CASP3 significantly, while this dose of genistein had a tendency 
to down-regulate P53 and to up-regulate CASP8. 
The high dose of genistein (50µg/g) increased autophagy-related genes ATG4b 
and ATG12l significantly; the same dose of genistein decreased CASP3 in a 
significant manner; it tended to decrease P53, although not significantly, and to 
increase CASP8, even if  also this effect was not significant. 
E2, instead, increased only CASP8 in a significant way, while a tendency to 














Fig. 25 Effects of E2 and genistein (5µg/g and 50µg/g) on apoptosis-related genes and 
autophagy-related genes of Oncorhynchus mykiss in white muscle. Gene expression data 
are presented as relative units using Ubiquitin and EF1α as housekeeping genes. Data 
are shown as means ± S.E.M. Treatments bars are relative to the control. Different 
letters indicate significant differences, P< 0,05. CASP3, Caspase 3; CASP8, Caspase 8; 
P53, Tumor protein; LC3b, light chain 3b protein; ATG4b, autophagy related 4, 



























Fig.25 Cell viability profile of rainbow trout adipocytes under different treatments 
measured using the MTT assay. Data are means ± SEM of 4 independent experiments. 
Cell viability is relative to the control value. P value <0.05. 
To investigate cell proliferation of the adipocytes in culture, MTT assay was 
performed. The results obtained with the MTT assay performed after 24h of E2 
and genistein stimulation at two different doses, are shown in fig.23. After 24h 
post-stimulation, genistein showed a clear dose-response curve, with significant 
decrease in cell proliferation at the concentration of 100µM with respect to the 
control and between two concentrations (Fig.25). Moreover, it was observed 
that genistein at 100µM+ Fulvestrant (an inhibitor of ERs) had the same effect 
of genistein at 100µM, namely decreased cell viability in the same proportion,  
indicating that an high dose of genistein had a significant effect on cell viability 
and the proliferation cells, but  it didn’t, either alone or in combination with 
fulvestrant, exert this effect via estrogen receptor-dependent mechanism. 

















Fig.26 Lipid content profile of rainbow trout adipocytes under different treatments 
measured using the ORO assay. Data are means ± SEM of 4 independent experiments. 
Lipid content is relative to the control value. P value <0.05. 
 
To investigate the differentiation of rainbow trout adipocytes in culture and to 
quantify lipid content of the cells, ORO assay was performed. The results 
obtained with the ORO assay performed after 72h of E2 and genistein 
stimulation at two different doses, are shown in fig.26. After 72h post-
stimulation, the high dose of genistein (100µM) showed a clear anti-
differentiation effect,where genistein at 10µM  hadn’t significant effect on cell 
differentiation, as well as E2. Interestingly, genistein at 100µM+Fulvestrant, (an 
inhibitor of ERs), had the same effect of genistein at 100µM, namely it 
decreased specific lipid content of adipocytes significantly. Also in this case, as 
for cell viability and cell proliferation, data suggest that genistein exerts its 




5.1 Effects in adipose tissue and liver 
In vivo results from this study showed that genistein had an unclear effect on 
adipose tissue of Oncorhynchus mykiss, increasing FAS, PPARβ, GAPDH and 
LXR  expression.  In fact, while FAS and GAPDH are two lipogenic genes, and 
this would lead us to consider genistein as adipogenic compound, PPARb and 
LXR have a controversial role in fish and in mammalian adipose tissue. FAS is 
a key enzyme involved in “de novo” lipogenesis that catalyzes the synthesis of 
long chain fatty acids, mainly by catalyzing acetyl coenzyme A and malonyl 
coenzyme A in all vertebrats (Smith et al., 2003); GAPDH is a lipogenic 
enzyme involved in cell differentiation in mammals and in fish (Bouraoui, et al., 
2008). Regarding PPARβ, little is known about it in the context of target tissues, 
target genes, lipid homeostasis, and functional overlap with PPARα, and PPARɤ 
(Dressel et al., 2003). In mammalian adipose tissue, this gene is not directly 
implicated in the control of adipogenesis, because alone is not able to promote 
lipogenesis (but only together with PPARɤ), however, it plays a role in the 
adaptive response of adipose tissue to dietary fatty acid content (Neels and 
Grimaldi, 2014). It has been reported that PPARβ expression in adipose tissue 
changes with nutritional situation in trout (Cruz-Garcia et al., 2015), and it 
seems to mediate lipolytic effects in gilthead sea bream (Cruz-Garcia et al., 
2009). Regarding LXR, some studies showed that it induces lipogenic genes, 
adipogenesis and lipid accumulation in adipose tissue (Juvet et al., 2003; Seo et 
al., 2004), others demonstrated opposite results (Ross et al., 2002; Stulnig et al., 
2002; Hummasti et al., 2004; Sekiya et al., 2007; Stenson et al., 2011). 
Nevertheless, recent studies in humans and mice demonstrate that LXR seems 
to be more involved in lipid mobilization than lipogenesis in adipose tissue 
(Korach-Andrè et al., 2011; Stenson et al., 2011). No information is available 
on the role of LXR in teleost adipose tissue, only in  Oncorhynchus mykiss, a 
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group of researchers (Cruz-Garcia et al., 2012) studied its possible roles, 
showing that it seems to regulate cholesterol transport through ABCA1 (ATP-
binding cassette transporter A1), and it is not related to synthetic pathways in 
trout adipose tissue, but it could be considered an indicator of increased 
lipolysis in this tissue, a phenomen described already in Sparus aurata fed 
vegetable ingredients (Cruz-Garcia et al., 2011; Albalat et al., 2005a).  
Unfortunately, we have not studies on genistein’s effects on lipid metabolism in 
fish in order to do a comparisons, only one done by Cleveland and Manor 
(2015) on effects of genistein in rainbow trout, however the effects in adipose 
tissue were not studied. Rather, several studies on mammals have been reported, 
showing anti-obesogenic effects of genistein in adipose tissue, through up-
regulation of β-oxidation-related genes (as PPARα), and down-regulation of  
LXRs (Mi-Hyun Kim et al., 2010). Furthermore, genistein stimulated a dose-
dependent increase in lipolysis, and restricted fatty acid synthesis and/or their 
esterification in rat adipocytes (Kandulska, et al., 1999; Szkudelska, et al., 
2002), and decreased adipose weight and adipocyte circumference at higher 
doses, and lipoprotein lipase (LPL) mRNA in mice (Naaz, et al., 2003). 
In fish, we have only studies that showed the effects of dietary vegetable oil (as 
soybean oil) on adipose tissue and also in hepatic lipid metabolism–related 
genes, lipid deposition, growth or tissue fatty acids composition. Therefore, 
there are previous studies on gilthead seabram (Sparus aurata) showed that 
plant components increase basal lipolysis levels in adipocytes (Albalat et al., 
2005a) as well as it was observed in the measurements of the basal lipolysis 
levels in isolated adipocytes from animals fed vegetable oils (66%VO). This is 
in agreement with an enhanced HSL activity, and up-regulation of LXR 
expression in adipocytes by 66%VO. Furthermore, liver weight values were 
higher in fish fed 66%V0, suggesting that the fatty acids released from adipose 
tissue could produce lipid accumulation in the liver, as previously suggested 
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(Benedito-Palos et al., 2008), and as it has been described in humans (Browning 
and Horton, 2004) (Cruz-Garcia, et al., 2011). Also Caballero et al. (2004) 
found that a diet with 60% soybean oil as replacement induced fat liver 
accumulation and steatosis in sea bream. The authors concluded that the 
reduction of dietary essential fatty acids due to the inclusion of vegetable oil, 
and the type of non-essential fatty acid included in the diet, affects hepatic 
morphology and lipid content (Bouraoui, et al., 2011). Similar effects were seen 
by Li et al., (2015) in blunt snout bream (Megalobrama amblycephala), where 
an increasing SO (soybean oil) levels in the diet (from 20% to 100%) down-
regulated PPARα and PPARβ expression, explaining the increase in lipid 
accumulation in the liver (Li, et al., 2015). Nevertheless, many other factors 
beside genistein, can affect lipid metabolism in these vegetable diets studies. 
In our study, genistein had a lipolytic effect in liver of rainbow trout, underlined 
by an increase of HSL expression, and by tendency to increase PPARα. 
Previously, the same lipolytic effect  of genistein was seen in other studies, in 
which genistein decreased lipogenesis in rat liver, through a reduction in fatty 
acid synthesis and an increase in β-oxidation (Takahashi, et al., 2009). Genistein 
decreased fat liver accumulation, reducing levels of hepatic TG and cholesterol, 
increasing PGC-1 (PPARɤ co-activator involved in mitocondrial fatty acids 
oxidation) mRNA, mitochondrial medium chain acyl-CoA dehydrogenase 
(MCAD) (PPARα target gene, involved into fatty acid β-oxidation) mRNA, and 
uncoupling protein (UCP-2) (a mitochondrial inner-membrane protein that 
mediates proton leakage by uncoupling adenosine triphosphate synthesis) 
mRNA levels, up-regulation of which may compromise cellular adenosine 
triphosphate levels and decrease metabolic efficiency and, thus, decrease fat 
accumulation (Lee, et al., 2006). Through plasma analysis of Oncorhynchus 
mykiss, with a significant decrease of TAG levels or increase of NEFA levels, a 
similar lipolytic effect of genistein was seen (Lutfi, et al., 2015 unpublished). 
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Also a previous study regarding the effects of genistein on growth-related and 
lipogenic-genes in rainbow trout (Cleveland and Manor, 2015) showed that E2 
and genistein promote changes in gene expression that support a regulation of 
lipid metabolism in liver.  
Moreover, the high dose of genistein, along with E2, can have estrogenic effects 
in liver, evidenced as up-regulation of vitellogenin (VTG). Therefore, up-
regulation of this gene in fish exposed to genistein, confirm the ability of this 
phytoestrogen to produce estrogenic effects in vivo (Pelissero et al., 1991; Inudo 
et al., 2004; Kaush et al., 2008; Schiller et al., 2014). Like in previous studies, 
in which a similarity between E2 and genistein responses in liver suggested that 
effects of genistein are partially mediated through activation of estrogen 
receptors (ERs) (Cleveland, et al., 2015), also in this study, it seemed to be a 
certain parallelism between the effects of estradiol and those corresponding to 
the high dose of genistein on ER2β (down-regulation) and VTG (up-regulation) 
expression in liver. Moreover, as in other studies (Cleveland, et al., 2015), genes 
expression responses to genistein increased with injected amount, indicating 
that the estrogenic response in vivo can be dose-dependent, and therefore could 
vary depending on the amount of phytoestrogens in the diet. 
Studies on mammals indicate that genistein may affect lipid metabolism through 
additional mechanisms, not only through activation of ERs; however for some 
effect it was not discovered a mechanism of action yet. For example, genistein 
can have an anti-obesogenic role, decreasing food intake and increasing body 
weight loss (Kim et al., 2006), or decreasing leptin secretion (Brennan and 
Mantzoros, 2006) or inhibiting leptin synthesis (Phrakonkham, et al., 2008). In 
vitro genistein can also induce on 3T3-L1 mouse adipocyte apoptosis, which 
may be contributor to genistein’s reducing effect on body weight (Kim, et al., 
2006), but the pathway is unknown at the moment. For the other anti-
obesogenic effects of genistein, instead, the mechanism of action has been 
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clarified. In fact, this phytoestrogens is capable of inhibiting  lipid accumulation 
in primary human pre-adipocytes, via down-regulation of PPARɤ, C/EBPα, and 
glycerol-3-phosphate dehydrogenase (Park et al., 2009), and inhibiting the 
antilipolytic action of insulin, through an activation of protein kinase A and 
elevation of cAMP levels (Szkudelska et al., 2008). In Oncorhynchus mykiss, 
we observed  as the in vivo effects of genistein are partially estrogen receptor-
dependent in liver; then, genistein may act through the autophagic way, as 
shown by an increase of autophagy-related genes LC3b in adipose tissue, and 
ATG4b both in liver and adipose tissue, while these effects were not observed 
after estrogen administration. This autophagic pathway could be considered as 
possible way through which genistein exerts its lipolytic role in liver. Finally, 
apoptotic pathway was analyzed in order to see if a potential anti-obesogenic 
effect of genistein happened through an activation of apoptosis in adipose 
tissue; differently from it was expected and observed in mammals, genistein not 
seemed to affect apoptosis-related genes significantly, while it not seemed to 
have an apoptotic effect in vivo, rather it was seen a decrease of CASP3 caused 
by genistein at lower concentration (5µg/g) in adipose tissue; this, in agreement 
with that reported by Alan et al., (1999) according to them CASP3 is essential 
for certain processes associated with the dismantling of the cell and the 
formation of apoptotic bodies, in particular it is is required for some typical 
hallmarks of apoptosis, and is indispensable for apoptotic chromatin 
condensation and DNA fragmentation in all cell types examined (Alan et al., 
1999). 
Regarding autophagy pathway, what we observed in our work is in agreement 
with the recently reported by Kuma et al., (2010), namely autophagy 
involvement in lipid metabolism of liver and adipose tissue. Inhibition of 
autophagy in hepatocytes in vitro and in vivo leads to an increase in triglyceride 
storage in lipid droplets (Komatsu et al., 2005; Singh et al., 2009). Moreover, it 
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was proposed that lipid droplets are sequestered and degraded through 
autophagy during starvation (Singh et al., 2009), which would lead us to believe 
that lipolytic role of genistein in liver detected in our study could be positive 
avoiding excessive lipid accumulation in liver. These findings indicate a new 
role for autophagy in regulating intracellular lipid stores in the liver. Autophagy 
also has an impact  on adipogenesis. Autophagy is induced during in vitro 
adipogenesis (Baerga et al., 2009), and inhibition of autophagy impairs 
adipogenesis in cultured mouse embryonic fibroblasts and mouse adipose 
tissues (Baerga et al., 2009; Zhang et al., 2009; Singh et al., 2009) (Kuma et al., 
2010). This could induce us to think that genistein, increasing autophagy-related 
genes LC3b and ATG4b in adipose tissue, could promote “adipogenesis”, even 
if it is just an idea that need more studies to be clarified.  
Regarding in vitro studies, phytochemicals, as genistein, are considered in 
mammals potential agents to inhibit  proliferation and differentiation of pre-
adipocytes, stimulate lipolysis, and induce apoptosis of existing adipocytes in 
vitro, and reduce body weight and adipose tissues mass in animal models 
(Andersen et al., 2010). However, we don’t know how genistein affects in vitro 
preadipocyte proliferation and differentation in fish, in order to compare the 
present results, only studies in mammals have been reported. For example, one 
of these studies done on mammals showed that genistein inhibits the 
proliferation and differentiation of MCF-7 and 3T3-L1 cells via the regulation 
of ERα expression and induction of apoptosis in a concentration- dependent 
manner (Choi et al., 2014); the same results were obtained also in other works, 
with a difference: genistein may exert these effects through different 
mechanisms of action, as via Wingless and Int/β catenin (Wnt/β-catenin), such 
as Extracellular signal-regulated kinase/c-Jun-N-terminal kinase (ERk/JNK) 
signaling, in an estrogen-receptor independent manner (Behloul et al., 2013). In 
our work, to determine if the observed effects of genistein on rainbow trout 
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adipose tissue were connected with its estrogenic activity, adipocytes were also 
incubated with estradiol and fulvestrant, an inhibitor of ERs. It was observed 
that, in contrast  to genistein, estradiol did not affect preadipocyte cell 
proliferation and differentiation, and genistein, also in association with 
fulvestrant, decreased pre-adypocites cell proliferation and their specific lipid 
content. So, as in mammals, our  results in vitro from  MTT assay and ORO 
assay not only showed high dose of genistein (50µg/g) decreased in a dose-
dependent manner adipose tissue adipogenesis of rainbow trout, but also 
indicated that the observed effects of genistein were not mediated by estrogen 
receptor. These in vitro data are inconsistent with that obtained in vivo, because 
we didn’t have clear results regarding effects of genistein on rainbow trout lipid 
metabolism in adipose tissue. 
 
5.2 Effects in white muscle 
Results from this study showed that genistein affected lipid metabolism-related 
genes in white muscle of rainbow trout, up-regulating FAS, HSL, PPARα and 
PPARβ significantly. As previously cited, FAS is a lipogenic gene involved into 
fatty acids synthesis, while HSL is a lipolytic gene and PPARα and PPARβ 
arerelated to catabolisms of fatty acids. HSL is the principal enzyme that 
catalyzes the hydrolysis of triglycerides (Weil et al., 2012), PPARα and PPARβ 
are transcriptional factors that have been shown to stimulate fatty acid β-
oxidation in muscle, liver (PPARα) and adipose tissue (PPARβ) in fish (Cruz-
Garcia et al., 2011). This effect of genistein could be seen as a contribute to 
promote a lipid turnover in white muscle, allowing muscle to respond to the 
treatments with genistein with an increase of lipogenesis and lipolysis, in 
agreement with the high capacity of salmonid muscle to accumulate and to 
oxidize lipids (Cruz-Garcia et al., 2011). Regarding LXR, in our study, it was 
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observed that both doses of genistein rised it in the same way. However, it’s 
quite difficult to explaine this effect, because few studies have addressed the 
functional role of LXR in fish (Archer et al., 2008; Cruz-Garcia et al., 2009a; 
Cruz-Garcia et al., 2009b; Cruz-Garcia et al., 2011), whereas in mammals, it is 
known that LXRs are involved in the regulation of cholesterol homeostasis 
(Zhang and Mangelsdorf, 2002; Tontonoz and Mangelsdorf, 2003; Steffensen 
and Gustafsson, 2004), fatty acid synthesis (Repa et al., 2000; Schultz et al., 
2000), carbohydrate metabolism (Laffitte et al., 2003; Mitro et al., 2007) and 
anti-inflammatory effects (Fowler et al., 2003; Valledor, 2005), as they activate 
the transcription of genes involved in these processes. Mammalian muscle is a 
key regulator of lipid, particularly cholesterol, metabolism through the action of 
LXR (Muscat et al., 2002). In fish, one study was done by a group of 
researchers (Cruz-Garcia et al., 2011) in muscle trout, in vitro showing that 
LXR is hormonally regulated by insulin and GH, and in turn, it regulates the 
transcription of key genes (such as FAS, PPARα, LPL, PPARβ, ABCA1) 
involved in muscle lipid metabolism in trout. In particular, LXR may play a 
lipogenic role through insulin stimulation and a tendency to promote anabolic 
effects through GH on trout myocites. 
There is scarce information on the regulation of lipid metabolism in teleost 
muscle, although muscle accounts for a high proportion of the total weight of 
the animal and the final product in aquaculture. For this reason, this study was 
done also on lipid metabolism in muscle trout. Moreover, we have not other fish 
studies done on the effects of genistein in muscle lipid metabolism in order to 
do a comparisons, only some works in other animals. It was seen that soy 
isoflavones (which include a mixture of daidzein, genistein and glycitein) lead 
to improved growth performance, antioxidant capacity, carcass traits and meat 
quality in several studies (Cook et al., 1998; Payne et al., 2001). Furthermore, 
isoflavones may have efficacy as a feed supplement to decrease fat deposition in 
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animals because of its estrogen-like function (Payne et al., 2001). Cook (1998) 
evaluating the in vivo effects of dietary soybean isoflavones on carcass muscle 
content and body growth rate in pigs, observed that the isoflavones (670 mg 
genistein, 705 mg daidzein and 210 mg glycitein/kg diet) increased growth rate 
and carcass muscling, but carcass fat was not affected in pigs from 6 to 32 kg of 
body weight. Similar results for rats are reported by Cook (1998). Payne et al. 
(2001) reported that addition of isoflavones to a corn-soy protein concentrate 
diet (C-SPC), increased carcass leanness and decreased carcass fat and results in 
carcass traits similar to, or better than, those of barrows fed corn-soybean meal 
(C-SBM) (Payne et al., 2001).  
However, a few of studies on the effects of individual flavonoid compounds (as 
genistein) were performed. A study done by Kamboh et al. (2013) on the effects 
of genistein on growth, meat characteristics, oxidative stability of lipids and 
sensory quality of raw meat in chickens showed that genistein reduced lipid 
oxidation in muscle, without affecting the sensory quality of breast meat, and in 
general improved meat quality in a dose-dependent manner. In an other study 
Kamboh et al., (2013) showed that genistein decreased cholesterol and 
tryglicerides levels in breast muscle with increasing levels of this 
phytoestrogen, and also fatty acids composition of chicken meat was improved 
in a dose-dependent way.  
Flesh  quality  of  fish  is  strongly  influenced  by  diet.  Carotenoids, lipid 
sources, antioxidants, and other dietary components can  affect  color  (Nickell 
et al., 1998; Coral et al., 1998),  fatty  acid  profile  (Waagbo et al., 1993; 
Skonberg et al., 1994),  texture (Rora et al., 2003; Faergemand et al., 1995), and 
flavor (Johnsen et al., 1991; Skonberg et al., 1993) of farm-raised fish. 
Similarly, the absorption of feed components such as isoflavones in the fish 
muscle may offer additional benefits to consumers (D’Souza et al., 2005). 
Although few of studies was done on the effects of genistein in fish muscle, first  
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step  toward  explaining  the  effects  of individual  soy  components (as 
genistein)  on  some  of  the  important  quality attributes of fish it was a study 
done by D’Souza et al., (2005) on rainbow trout white muscle, in which the 
authors showed that dietary genistein resulted in genistein deposition in fish 
flesh without adversely  affecting  the  flavor, color,  or  proximate composition 
of the fillets; however, the genistein  levels  found  in  trout  fillets  were  much  
lower  than that found in commercial soy foods, for example, tofu and tempeh, 
which contain approximately 20.6 and 24.8 mg of genistein/100 g of sample 
(U.S. Department of Agriculture, 2002). It is for this reason that it is difficult to  
draw  any  conclusions  about  the  potential  human health benefits from these 
low amounts of genistein. More studies are needed to understand the effects of 
dietary genistein on the oxidative stability of fish fillets. Another study in trout, 
instead, showed that the high doses of genistein affects muscle protein turnover 
by increasing rates of protein degradation and proteolysis-related gene 
expression, via estrogen receptor-dependent and –independent mechanisms, so 
to have negative effects on skeletal growth (Cleveland et al., 2014).  
More studies on the effects of partial or total replacement of fish meal/oil by 
soybean or, in general, by vegetable meal/oils on growth, muscle fatty acid 
composition and organoleptic quality of flesh were performed. It was seen that 
inclusion of vegetable oils in fish diets modifies body fatty acid profiles and 
may significantly affect fish flesh quality and sensory characteristics (Guillou et 
al., 1995; Morris et al., 1995). For example, in one of these studies lipid 
concentrations in the muscle of cobia fed soy-based diets were found to 
significantly increase with an increase in soybean meal, while muscle ash and 
protein varied without a definite trend (Chou et al., 2004); in an other work, 
Izquierdo et al. (2005) observed that it is possible to substitute up to 60% fish 
oil by vegetable oils in diets for gilthead seabream without affecting growth and 
feed utilization even for a long feeding period.  
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In the present study, genistein’s possible-mechanisms of action were also 
studied, in particular the autophagy and apoptotic pathways. Regarding 
autophagy, in mammals several changes occur during catabolic conditions: 
proteins are mobilized to sustain gluconeogenesis in the liver and to provide 
alternative energy substrates for organs, mitochondrial and sarcoplasmic 
networks are remodeled and myonuclei are lost. In addition, the daily 
contractions can mechanically and metabolically damage/alter muscle proteins 
and organelles. Muscle cells therefore require an efficient system for removing 
and eliminating unfolded and toxic proteins as well as abnormal and 
dysfunctional organelles. The autophagy system is responsible for this action, 
generating double membrane vesicles that engulf portion of cytoplasm, 
organelles, glycogen and protein aggregates (Levine and Kroemer, 2008; 
Mizushima et al., 2008). Autophagosomes are then delivered to lysosomes for 
degradation of their contents. Despite this important function, the role of 
autophagy in the control of muscle mass has only recently begun to be 
investigated (Sandri, 2010). It was observed that an inhibition/alteration of 
autophagy can contribute to myofiber degeneration and weakness in muscle 
disorders characterized by accumulation of abnormal mitochondria and 
inclusions (Masiero et al., 2009). As in mammals, also in fish the autophagic 
proteolytic system represents a largely non-selective route of protein 
degradation which serves to recycle amino acids during periods of amino acid 
or energy deficiency (Kuma and Mizushima, 2010). This pathway has been 
implicated as a major contributor to increased muscle proteolysis during sexual 
maturation in salmon and rainbow trout (Yamashita and Konagaya, 1990; 
Cleveland et al., 2012). 
In mammals different signaling pathways may control autophagosome 
formation during short (hours) or long (days) periods of induced autophagy. 
Denervation is able to induce autophagy in skeletal muscles, although at a 
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slower rate than after fasting (O’Leary and Hood, 2008; O’Leary and Hood, 
2009). This  effect is mediated by Runx1 (an autophagy suppressor), which is 
upregulated in denervated muscles and is required to preserve muscle mass 
(Wang et al., 2005). The mechanisms of Runx1-mediated autophagy 
suppression is unclear but recent evidence shows that Runx1 can inhibit FoxO3 
action (Wildey and Howe, 2009). Another negative regulator of autophagy in 
muscle cells is the phosphatase Jumpy. Reduction of Jumpy protein by RNAi 
results in the formation of autophagosomes in C2C12 myoblasts and an 
increased rate of proteolysis observed both in normal and starvation media 
(Vergne et al., 2009). However, the regulation of Jumpy in normal and atrophic 
muscles is still unknown. The most potent autophagy inhibitor in skeletal 
muscles is the kinase Akt. Acute activation of Akt in adult mice or in muscle 
cell cultures completely inhibits autophagosome formation and lysosomal-
dependent protein degradation during fasting (Mammucari et al., 2007; Zhao et 
al., 2007; Zhao et al., 2008). Mammalian TOR (mTOR) is a nutrient-sensitive 
kinase downstream of Akt that is important for cell growth. However, the role 
of mTOR in autophagy regulation is not so important and therefore, mTOR, at 
least in skeletal muscles, does not mediate the negative effect of Akt on the 
autophagy pathway. The upregulation of several autophagy-related genes in 
atrophying muscles (Lecker et al., 2004; Mammucari et al., 2007; Zhao et al., 
2007; O’Leary and Hood, 2008; O’Leary and Hood, 2009) suggests the 
contribution of one or more transcription factors to autophagy regulation. 
Recently, it was identified  FoxO3 as the critical factor for autophagy control in 
adult muscles. Expression of FoxO3 is sufficient and required to activate 
lysosomal-dependent protein breakdown in cell culture and in vivo. Moreover 
several autophagy genes including LC3, Gabarap, Bnip3, VPS34, ATG12 are 
under FoxO3 regulation. Recently, the p38 αβ MAPK pathway was also 
described to regulate expression of autophagy-related genes independently of 
FoxO3 during oxidative stress (McClung et al., 2009). Differently from 
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mammals, the mechanisms responsible for the regulation of autophagy have not 
been investigated in teleosts, known to exhibit different muscle growth 
dynamics. One study was done by Seiliez et al., (2010), in which the authors 
investigated both in vivo and in vitro the transcriptional regulation of several 
major genes involved in autophagy (LC3b, gabarapl1, ATG12l, ATG4b) in the 
white skeletal muscle of rainbow trout.  
In mammals, FoxO transcritional factors are also known as a downstream target 
of the IGF1/insulin-PI3K-Akt signalling pathway; when the IGF1/insulin-PI3K-
Akt axis is active, FoxO proteins are phosphorylated and sequestered in the 
cytosol, but in catabolic states, the unphosphorylated transcription factors enter 
the nucleus and induce different proteasome- and autophagy-related genes 
(Sandri et al., 2004; Mammucari et al., 2007; Zhao et al., 2007). To examine the 
involvement of the Akt–FoxO signalling pathway in the regulation of the 
autophagy-related gene expression in trout, Seliez et al. (2010) investigated the 
specific effect of IGF1 on the Akt–FoxO signalling pathway and the expression 
of autophagy-related genes in cell culture model. IGF1 induced the 
phosphorilation of Akt and FoxO3 in primary culture of trout muscle cells, but 
had a weak or no effect on the expression of autophagy-related genes, 
suggesting a moderate role for FoxO3 in the regulation of the expression of the 
autophagy-related genes in trout myocytes. For the first time they showed the 
existence and the regulation of genes involved into autophagy in fish, and the 
overexpression of the autophagy-related genes during starvation to indicate that 
in rainbow trout muscle, these genes are regulated by the feeding status 
similarly to what is observed in mammals (Seiliez et al., 2010).  
In a study of Cleveland (2014) on rainbow trout skeletal muscle, it was seen that 
high concentrations of genistein, increased autophagy-related genes, among 
which ATG4b, to support the idea that dietary genistein potentially could be 
considered as a regulator of autophagy, implicated into protein degradation 
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process. Also in our study, the high dose of genistein (50µg/g) increased 
ATG4b and ATG12l. So, we can suppose that, in a similar way than in trout 
liver, genistein may act through the autophagic pathway in order to exert its 
lipolytic role into rainbow trout white muscle.  
In our study, also a lipogenic role of genistein into trout white muscle was 
observed, as shown by a significant increase of FAS enzyme involved into fatty 
acid synthase, and LXR. In mammals, lipotoxicity (excess lipid accumulation 
resulting from an elevated supply of plasma fatty acids) leads to cellular 
dysfunction and death in non-adipose tissues including the heart, pancreas and 
liver. While lipoapoptosis has been shown in cultured skeletal muscle cells (by 
several specific measures, including caspase-3 activation) (Turpin et al., 2006), 
in vivo instead, it was observed as a lipid overload did not induce skeletal 
muscle apoptosis (Turpin et al., 2009). In our in vivo study, both doses of 
genistein decreased apoptosis-related gene CASP3 significantly, so we can 
suppose that genistein, despite its possible obesogenic role, is capable of protect 
trout muscle cells against an eventual lipid overload-induced cell apoptosis. Or 
simply, a possible excessive lipid accumulation in trout muscle caused by 
genistein and following lipid overload-induced cellular apoptosis, can be 
counteracted by skeletal muscle itself, considering that, as in mammals as in 
fish, unlike the pancreas and liver, this tissue has a comparatively large capacity 
to oxidize FAs that may afford the tissue protection from lipoapoptosis. At the 
moment, these are only speculations that need additional studies to be 
investigated. 
Regarding the supposed anti-obesogenic role of genistein, it is not possible to 
assert that, because of results obtained, genistein exerts it through apoptotic 
pathway in trout white muscle. 
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Differently from the previous studies and unlike we obtained in adipose tissue 
and liver, the effects of genistein in trout white muscle were not dose-
dependent, except in the case of autophagy-related genes ATG4b and ATG12l. 
Regarding the estrogenic activity of phytoestrogen genistein, even in rainbow 
trout  muscle, it was seen a certain parallelism between genistein and E2; in 
particular, it was observed a similarity between the effects of the lower dose of 
genistein and those of E2 on PPARβ  (up-regulation), and between the effects of 
the high dose of genistein and those of E2 on ER2α (mild up-regulation), 
suggesting that genistein role could be partly mediated by estrogen receptors, as 
in trout liver. Likewise in a previous study (Cleveland, 2014) it was observed 
that the high dose of genistein can exert its effects on protein turnover in trout 
muscle also via estrogen-receptors.  
 
6.  Conclusions 
From the current study it resulted that genistein can have in vitro anti-
obesogenic effects on rainbow trout pre-adipocytes via estrogen-receptor 
independent mechanism. In vivo unclear results about role of genistein in   
Oncorhynchus mykiss adipose tissue were obtained. 
Regarding liver, genistein had a clear lipolytic effect in vivo, with a significant 
increase of HSL expression, mediated also by a possible autophagic way, 
enhancing a process that, along with lipolysis, contributes to lipid droplets and 
triglycerides breackdown. In liver, genistein seems to have a partial estrogenic 
role. 
The in vivo and in vitro anti-adipogenic effect of high dose of genistein 
(50µg/g) in liver and adipose tissue respectively, showed that genistein exerts  
its role in a dose-dependent way. Globally, data obtained are very interesting 
both in order to avoid an excess of adiposity of the animal that might affect 
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sensory and organoleptics characteristics of the fish, which can have a benefit in 
aquaculture. 
In vivo results obtained in trout white muscle, showed that genistein affected 
lipid metabolism-related genes in this tissue, up-regulating FAS, HSL, PPARα 
and PPARβ significantly. This double effect of genistein (lipogenic and 
lipolytic effect) could be positive if interpreted as a contribute to promote a lipid 
turnover in trout white muscle. 
Regarding genistein’s mechanisms of action, it was seen that genistein could 
exert its lipolytic role in trout muscle via autophagic way, increasing ATG4b 
and ATG12l, not through the apoptotic pathway, because of it decreased 
CASP3 significantly, with a tendency to decrease P53. Rather, this down-
regulation of CASP3 expression involved into apoptosis process, could be seen 
as a capacity of genistein to counteract an eventual lipid overload-induced 
muscle cell apoptosis. 
The effects of genistein on lipid-metabolism and apoptosis-related genes in trout 
muscle were not dose-dependent, only on autophagy-related genes ATG4b and 
ATG12l. Moreover, a partial estrogenic activity of this phytoestrogen was also 
seen. 
Definitely, our data need additional studies both to clarify the in vivo effect of 
genistein on rainbow trout lipid metabolism in adipose tissue, along with its 
mechanisms of action, and to better understand if the autophagic way in adipose 
tissue could be a possible pathway through which genistein may exert a possible 
adipogenic role, directed to the maintenance of the adipose tissue healthy and 
funcionality.  
Regarding rainbow trout white muscle, instead, further studies would be 
necessary to confirm the double role of genistein in this tissue, and to 
investigate if genistein can be seen as a possible compound counteracting 
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cellular apoptotis induced by an eventual lipotoxicity. These data will contribute 
to know if the inclusion of soybean (that is rich in genistein) into Oncorhynchus 
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